0001144204-17-026247.txt : 20170511 0001144204-17-026247.hdr.sgml : 20170511 20170511080112 ACCESSION NUMBER: 0001144204-17-026247 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 46 CONFORMED PERIOD OF REPORT: 20170331 FILED AS OF DATE: 20170511 DATE AS OF CHANGE: 20170511 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cellectar Biosciences, Inc. CENTRAL INDEX KEY: 0001279704 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043321804 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-36598 FILM NUMBER: 17832566 BUSINESS ADDRESS: STREET 1: 3301 AGRICULTURE DRIVE CITY: MADISON STATE: WI ZIP: 53716 BUSINESS PHONE: 617-244-1616 MAIL ADDRESS: STREET 1: 3301 AGRICULTURE DRIVE CITY: MADISON STATE: WI ZIP: 53716 FORMER COMPANY: FORMER CONFORMED NAME: NOVELOS THERAPEUTICS, INC. DATE OF NAME CHANGE: 20050617 FORMER COMPANY: FORMER CONFORMED NAME: COMMON HORIZONS INC DATE OF NAME CHANGE: 20040211 10-Q 1 v466189_10q.htm FORM 10-Q

 

 

 

U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

FORM 10-Q

 

[mark one]

xQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended: March 31, 2017

 

¨TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ______________ to ______________

 

Commission File Number 1-36598

 

 

 

CELLECTAR BIOSCIENCES, INC.
(Exact name of registrant as specified in its charter)

 

DELAWARE   04-3321804
(State or other jurisdiction of
incorporation or organization)		  

(IRS Employer

Identification No.)

 

3301 Agriculture Drive

Madison, Wisconsin 53716

(Address of principal executive offices)

 

(608) 441-8120

(Registrant’s telephone number, including area code)

 

(Former name, former address and former fiscal year, if changed since last report)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes x       No ¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ¨ Accelerated filer ¨
Non-accelerated filer ¨ (Do not check if a smaller reporting company) Smaller reporting company x
    Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes ¨      No x

 

Number of shares outstanding of the issuer’s common stock as of the latest practicable date: 13,462,170 shares of common stock, $0.00001 par value per share, as of May 8, 2017.

 

 

 

 

CELLECTAR BIOSCIENCES, INC.

 

FORM 10-Q INDEX

 

PART I.  FINANCIAL INFORMATION 3
     
Item 1. Financial Statements 3
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 14
Item 4. Controls and Procedures 17
     
PART II.  OTHER INFORMATION 18
     
Item 1. Legal Proceedings 18
Item 1A. Risk Factors 18
Item 6. Exhibits 19

 

 2 

 

 

PART I. FINANCIAL INFORMATION

 

Item 1. Financial Statements

 CELLECTAR BIOSCIENCES, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)

 

   March 31,
2017		   December 31,
2016		 
ASSETS          
CURRENT ASSETS:          
Cash and cash equivalents  $11,238,394   $11,444,619 
Restricted cash   55,000    55,000 
Prepaid expenses and other current assets   893,185    693,569 
Total current assets   12,186,579    12,193,188 
FIXED ASSETS, NET   1,423,448    1,444,058 
GOODWILL   1,675,462    1,675,462 
OTHER ASSETS   11,872    11,872 
TOTAL ASSETS  $15,297,361   $15,324,580 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY          
CURRENT LIABILITIES:          
Current maturities of notes payable  $—   $86,591 
Accounts payable and accrued liabilities   1,186,092    1,416,433 
Derivative liability   209,600    127,125 
Capital lease obligations, current portion   2,801    2,727 
Total current liabilities   1,398,493    1,632,876 
LONG-TERM LIABILITIES:          
Deferred rent   145,367    146,583 
Capital lease obligation, less current portion   4,520    5,249 
Total long-term liabilities   149,887    151,832 
TOTAL LIABILITIES   1,548,380    1,784,708 
COMMITMENTS AND CONTINGENCIES (Note 8)          
STOCKHOLDERS’ EQUITY:          
Preferred stock, $0.00001 par value; 7,000 shares authorized; none and 17 Series A issued and outstanding as of March 31, 2017 and December 31, 2016, respectively   —    875,572 
Common stock, $0.00001 par value; 40,000,000 shares authorized; 13,458,170 and 10,368,325 shares issued and outstanding at March 31, 2017 and December 31, 2016, respectively   135    104 
Additional paid-in capital   87,427,196    83,451,222 
Accumulated deficit   (73,678,350)   (70,787,026)
Total stockholders’ equity   13,748,981    13,539,872 
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY  $15,297,361   $15,324,580 

 

The accompanying notes are an integral part of these financial statements.

 

 3 

 

 

CELLECTAR BIOSCIENCES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

 

   Three Months Ended
March 31,		 
   2017   2016 
         
COSTS AND EXPENSES:          
Research and development  $1,856,880   $1,039,454 
General and administrative   955,356    961,254 
Total costs and expenses   2,812,236    2,000,708 
           
LOSS FROM OPERATIONS   (2,812,236)   (2,000,708)
           
OTHER INCOME (EXPENSE):          
Gain (loss) on revaluation of derivative warrants   (82,475)   2,824,722 
Interest income, net   3,387    549 
Total other income (expense), net   (79,088)   2,825,271 
NET INCOME (LOSS)  $(2,891,324)  $824,563 
BASIC NET INCOME (LOSS) PER COMMON SHARE  $(0.24)  $0.96 
SHARES USED IN COMPUTING BASIC NET INCOME (LOSS) PER COMMON SHARE   12,010,284    858,107 
DILUTED NET INCOME (LOSS) PER COMMON SHARE  $(0.24)  $0.91 
SHARES USED IN COMPUTING DILUTED NET INCOME (LOSS) PER COMMON SHARE   12,010,284    906,381 

 

The accompanying notes are an integral part of these financial statements.

 

 4 

 

 

CELLECTAR BIOSCIENCES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

 

   Three Months Ended
March 31,		 
   2017   2016 
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net income (loss)  $(2,891,324)  $824,563 
Adjustments to reconcile net income (loss) to cash used in operating activities:          
Depreciation and amortization   86,911    90,773 
Stock-based compensation expense   165,674    102,918 
(Gain) loss on revaluation of derivative warrants   82,475    (2,824,722)
Changes in:          
Accounts payable and accrued liabilities   (230,341)   (67,256)
Prepaid expenses and other current assets   (199,616)   55,793 
Other assets and liabilities   (1,216)   (325)
Cash used in operating activities   (2,987,437)   (1,818,256)
CASH FLOWS FROM INVESTING ACTIVITIES:          
Purchases of fixed assets   (66,301)   — 
Cash used in investing activities   (66,301)   — 
CASH FLOWS FROM FINANCING ACTIVITIES:          
Proceeds from exercise of warrants   2,934,759    — 
Payments on notes payable   (86,591)   (60,528)
Payments on capital lease obligations   (655)   (588)
Cash paid for issuance costs   —    (69,450)
Reverse stock split fractional shares   —    (594)
Cash provided by (used in) financing activities   2,847,513    (131,160)
NET DECREASE IN CASH AND EQUIVALENTS   (206,225)   (1,949,416)
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD   11,444,619    3,857,791 
CASH AND CASH EQUIVALENTS AT END OF PERIOD  $11,238,394   $1,908,375 
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION          
Cash paid for interest expense  $364   $1,467 

 

The accompanying notes are an integral part of these financial statements.

 

 5 

 

 

CELLECTAR BIOSCIENCES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

1. NATURE OF BUSINESS, ORGANIZATION AND GOING CONCERN

 

Cellectar Biosciences, Inc. (the “Company”) is a biopharmaceutical company developing compounds for the treatment and imaging of cancer. The Company’s headquarters are located in Madison, Wisconsin.

 

The Company is subject to a number of risks similar to those of other small pharmaceutical companies. Principal among these risks are dependence on key individuals, competition from substitute products and larger companies, the successful development and marketing of its products in a highly regulated environment and the need to obtain additional financing necessary to fund future operations.

 

The accompanying financial statements have been prepared on a basis that assumes that the Company will continue as a going concern and that contemplates the continuity of operations, realization of assets and the satisfaction of liabilities and commitments in the normal course of business. The Company has devoted substantially all of its efforts toward research and development and has, during the three months ended March 31, 2017, generated an operating loss of approximately $2,812,000. The Company expects that it will continue to generate operating losses for the foreseeable future.

 

The Company believes that its cash balance at March 31, 2017 is adequate to fund operations at budgeted levels into second quarter 2018. The Company’s ability to execute its operating plan beyond second quarter 2018 depends on its ability to obtain additional funding via the sale of equity and/or debt securities, a strategic transaction or otherwise. The Company plans to continue to actively pursue financing alternatives, but there can be no assurance that it will obtain the necessary funding, raising substantial doubt about the Company’s ability to continue as a going concern within one year of the date these financial statements are issued. The accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

The accompanying condensed consolidated balance sheet as of December 31, 2016 has been derived from audited financial statements. The accompanying unaudited condensed consolidated balance sheet as of March 31, 2017, the condensed consolidated statements of operations for the three months ended March 31, 2017 and 2016, the condensed consolidated statements of cash flows for the three months ended March 31, 2017 and 2016 and the related interim information contained within the notes to the condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and with the instructions, rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial information. Accordingly, they do not include all of the information and the notes required by U.S. GAAP for complete financial statements. In the opinion of management, the unaudited interim condensed consolidated financial statements reflect all adjustments which are of a nature necessary for the fair presentation of the Company’s consolidated financial position at March 31, 2017 and consolidated results of its operations for the three months ended March 31, 2017 and 2016, and its cash flows for the three months ended March 31, 2017 and 2016. The results for the three months ended March 31, 2017 are not necessarily indicative of future results.

 

These unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and related notes thereto included in the Company’s Form 10-K for the fiscal year ended December 31, 2016, which was filed with the SEC on March 15, 2017.

 

Principles of Consolidation — The consolidated financial statements include the accounts of the Company and the accounts of its wholly-owned subsidiary. All significant intercompany accounts and transactions have been eliminated.

 

Restricted Cash — The Company accounts for cash that is restricted for other than current operations as restricted cash. Restricted cash at March 31, 2017 and December 31, 2016 consisted of a certificate of deposit of $55,000 required under the Company’s lease agreement for its Madison, Wisconsin facility.

 

Goodwill — Goodwill is not amortized, but is required to be evaluated for impairment annually or whenever events or changes in circumstances suggest that the carrying value of an asset may not be recoverable. The Company evaluates goodwill for impairment annually in the fourth fiscal quarter and additionally on an interim basis if an event occurs or there is a change in circumstances, such as a decline in the Company’s stock price or a material adverse change in the business climate, which would more likely than not reduce the fair value of the reporting unit below its carrying amount. No such event or change in circumstances occurred; therefore, no changes in goodwill were made during the three months ended March 31, 2017 and 2016.

 

 6 

 

 

In January 2017, the FASB issued ASU No. 2017-04, Simplifying the Test for Goodwill. The standard streamlines the methodology for calculating whether goodwill is impaired based upon whether the carrying amount of goodwill exceeds the reporting unit’s fair value. ASU 2017-04 applies to public business entities and those other entities that have goodwill reported in their financial statements and have not elected the private company alternative for the subsequent measurement of goodwill and is effective for annual and interim reporting periods beginning after December 15, 2019, with early adoption permitted. The Company does not expect that the adoption of this standard will have a material effect on its financial statements.

 

Impairment of Long-Lived Assets — Long-lived assets other than goodwill consist primarily of fixed assets, which we periodically evaluate for potential impairment. Whenever events or circumstances change, an assessment is made as to whether there has been an impairment in the value of long-lived assets by determining whether projected undiscounted cash flows generated by the applicable asset exceed its net book value as of the assessment date. No such event or change in circumstances occurred; therefore, no such impairment occurred during the three months ended March 31, 2017 and 2016.

 

Stock-Based Compensation — The Company uses the Black-Scholes option-pricing model to calculate the grant-date fair value of stock option awards. The resulting compensation expense, net of expected forfeitures, for awards that are not performance-based is recognized on a straight-line basis over the service period of the award, which is generally three years for stock options. For stock options with performance-based vesting provisions, recognition of compensation expense, net of expected forfeitures, commences if and when the achievement of the performance criteria is deemed probable. The compensation expense, net of expected forfeitures, for performance-based stock options is recognized over the relevant performance period. Awards of stock that are not performance-based are valued at the fair market value on the date of the grant and are amortized over the service period of the award. Non-employee stock-based compensation is accounted for in accordance with the guidance of Financial Accounting Standards Board Accounting Standards Codification (“FASB ASC”) Topic 505, Equity.  As such, the Company recognizes expense based on the estimated fair value of options granted to non-employees over their vesting period, which is generally the period during which services are rendered and deemed completed by such non-employees.

 

Fair Value of Financial Instruments — The guidance under FASB ASC Topic 825, Financial Instruments, requires disclosure of the fair value of certain financial instruments. Financial instruments in the accompanying financial statements consist of cash equivalents, accounts payable and long-term obligations.  The carrying amount of cash equivalents and accounts payable approximate their fair value due to their short-term nature.  The carrying value of remaining long-term obligations, including the current portion, approximates fair value because the fixed interest rate approximates current market interest rates available on similar instruments.

 

Derivative Instruments — The Company generally does not use derivative instruments to hedge exposures to cash flow or market risks.  However, certain warrants to purchase common stock that do not meet the requirements for classification as equity, in accordance with the Derivatives and Hedging Topic of the FASB ASC, are classified as liabilities.  In such instances, net-cash settlement is assumed for financial reporting purposes, even when the terms of the underlying contracts do not provide for a net-cash settlement. These warrants are considered derivative instruments because the agreements contain a certain type of cash settlement feature, “down-round” provisions whereby the number of shares for which the warrants are exercisable and/or the exercise price of the warrants is subject to change in the event of certain issuances of stock at prices below the then-effective exercise price of the warrants. The number of shares issuable under such warrants was 533,065 at March 31, 2017 and December 31, 2016. The primary underlying risk exposure pertaining to the warrants is the change in fair value of the underlying common stock.  Such financial instruments are initially recorded at fair value with subsequent changes in fair value recorded as a component of gain or loss on derivatives on the consolidated statements of operations in each reporting period. If these instruments subsequently meet the requirements for equity classification, the Company reclassifies the fair value to equity. At March 31, 2017 and December 31, 2016, these warrants represented the only outstanding derivative instruments issued or held by the Company.

 

Leases — In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) which supersedes FASB ASC Topic 840, Leases (Topic 840) and provides principles for the recognition, measurement, presentation and disclosure of leases for both lessees and lessors. The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight-line basis over the term of the lease, respectively. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than twelve months regardless of classification. Leases with a term of twelve months or less will be accounted for similar to existing guidance for operating leases. The standard is effective for annual and interim periods beginning after December 15, 2018, with early adoption permitted upon issuance. The Company is currently evaluating the method of adoption and the impact of adopting ASU 2016-02 on its results of operations, cash flows and financial position.

 

 7 

 

 

2. FAIR VALUE

 

In accordance with Fair Value Measurements and Disclosures Topic of the FASB ASC 820, the Company groups its financial assets and financial liabilities generally measured at fair value in three levels, based on the markets in which the assets and liabilities are traded and the reliability of the assumptions used to determine fair value.

 

  · Level 1: Input prices quoted in an active market for identical financial assets or liabilities.
  · Level 2: Inputs other than prices quoted in Level 1, such as prices quoted for similar financial assets and liabilities in active markets, prices for identical assets, and liabilities in markets that are not active or other inputs that are observable or can be corroborated by observable market data.
  · Level 3: Input prices quoted that are significant to the fair value of the financial assets or liabilities which are not observable or supported by an active market.

 

To the extent that the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for instruments categorized in Level 3. A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.

 

The Company issued warrants to purchase an aggregate of 82,500 common shares in a February 2013 public offering (the “February 2013 Public Offering Warrants”). On February 20, 2014, 27,500 of the February 2013 Public Offering Warrants expired. On May 20, 2016, 16,250 warrants were exercised. The remaining 38,750 warrants are classified within the Level 3 hierarchy.

 

In August 2014, as part of an underwritten public offering, the Company issued 494,315 warrants to purchase common stock (the “August 2014 Warrants”). The August 2014 Warrants are listed on the NASDAQ Capital Market under the symbol “CLRBW,” however, there are certain periods where trading volume is low; therefore, they are classified as Level 2 within the hierarchy.

 

The following tables set forth the Company’s financial instruments carried at fair value using the lowest level of input applicable to each financial instrument as of March 31, 2017 and December 31, 2016:

 

   March 31, 2017 
   Level 1   Level 2   Level 3   Fair Value 
                 
Liabilities:                    
February 2013 Public Offering Warrants  $—   $—   $49,600   $49,600 
August 2014 Warrants   —    160,000    —    160,000 
Total  $—   $160,000   $49,600   $209,600 

 

   December 31, 2016 
   Level 1   Level 2   Level 3   Fair Value 
                 
Liabilities:                    
February 2013 Public Offering Warrants  $—   $—   $27,125   $27,125 
August 2014 Warrants   —    100,000    —    100,000 
Total  $—   $100,000   $27,125   $127,125 

 

 8 

 

 

In order to estimate the value of the February 2013 Public Offering Warrants considered to be derivative instruments, the Company uses a modified option-pricing model together with assumptions that consider, among other variables, the fair value of the underlying stock, risk-free interest rates, volatility, the contractual term of the warrants, future financing requirements and dividend rates. The future financing estimates are based on the Company’s estimates of anticipated cash requirements over the term of the warrants as well as the frequency of required financings based on its assessment of its historical financing trends and anticipated future events. Due to the nature of these inputs and the valuation technique utilized, these warrants are classified within the Level 3 hierarchy.

 

The following table summarizes the modified option-pricing assumptions used:

 

   Three Months
Ended
 March 31,
 2017		   Twelve Months
Ended
December 31,
2016		 
Volatility   118%   92.72-134%
Risk-free interest rate   1.03%   0.53-1.15%
Expected life (years)   0.89    1.14-1.89 
Dividend   0%   0%

 

During fiscal year 2016, the Company had warrants outstanding for part of the year that were considered financial instruments. Those warrants were either extinguished or amended such that they were no longer considered financial instruments as of December 31, 2016, and were, therefore, not financial instruments during the quarter ended March 31, 2017. The following table summarizes the modified option-pricing assumptions used for the period they were considered financial instruments:

 

   Twelve Months
Ended
 December 31,
 2016		 
Volatility   89.73%
Risk-free interest rate   1.65%
Expected life (years)   4.50 
Dividend   0%

 

The following table summarizes the changes in the fair market value of the Company’s warrants which are classified within the Level 3 fair value hierarchy.

 

   Three Months
Ended
 March 31,
2017		   Twelve Months
Ended
December 31,
2016		 
Beginning balance – Fair value  $27,125   $2,067,000 
Reclassification to equity for warrants that are no longer derivative liabilities   —    (1,392,429)
Loss (gain) on derivatives resulting from change in fair value or extinguishment   22,475    (647,446)
Ending balance – Fair value  $49,600   $27,125 

 

To estimate the fair value of the August 2014 Warrants, the Company calculated the weighted average closing price for the trailing 10 day period with trades that ended on the balance sheet date.

 

 9 

 

 

3. STOCKHOLDERS’ EQUITY

 

November 2016 Underwritten Offering

 

On November 23, 2016, the Company entered into an Underwriting Agreement with Ladenburg Thalmann & Co. Inc., as representative of the several underwriters named therein, in connection with the Company’s Registration Statement on Form S-1. Pursuant to the Underwriting Agreement, the Company agreed to sell to the Underwriter 800,000 shares of common stock, 68 shares of Series A preferred stock convertible into 4,533,356 shares of common stock and Series C warrants to purchase 5,333,356 shares of common stock, plus up to an additional 800,000 shares of common stock and Series C warrants to purchase up to an additional 800,000 shares of common stock in the event of the exercise by the Underwriter of its over-allotment option. The public offering price of a share of common stock together with a Series C warrant to purchase one share of common stock was $1.50. The public offering price to purchase one share of Series A preferred stock, each of which is convertible into 66,667 shares of common stock, together with a Series C warrant to purchase 66,667 shares of common stock was $100,000. The preferred stock was non-voting, had no dividend rights (except to the extent dividends were also paid on common stock), liquidation preference, or other preferences over common stock. The Series C warrants have an exercise price of $1.50 per share, and are exercisable for five years from the date of issuance. The net proceeds were allocated to each security based upon the pro-rata values of the underlying common stock and a Black-Scholes valuation of the warrants.

 

The sale of securities pursuant to the Underwriting Agreement, including the entire over-allotment option, closed on November 29, 2016 (the “November 2016 Underwritten Offering”). Gross proceeds were $9.2 million with net proceeds to the Company of approximately $8.3 million.

 

As of December 31, 2016, 17 shares of Series A preferred stock were outstanding. During the three months ended March 31, 2017, all 17 shares were converted into 1,133,339 shares of common stock.

 

During the three months ended March 31, 2017, Series C warrants representing 1,956,506 shares of common stock were exercised by the holders, for proceeds of $2,934,759.

 

April 2016 Underwritten Offering

 

On April 15, 2016, the Company entered into an Underwriting Agreement with Ladenburg Thalmann & Co., Inc. in connection with the Company’s Registration Statement on Form S-1. Pursuant to the Underwriting Agreement, the Company agreed to sell to the Underwriter 1,378,364 shares of common stock, Series B prefunded warrants to purchase 1,908,021 shares of common stock and Series A warrants to purchase 3,286,385 shares of common stock, plus up to an additional 492,957 shares of common stock and Series A warrants to purchase up to an additional 492,957 shares of common stock in the event of the exercise by the Underwriter of its over-allotment option. The public offering price of a share of common stock together with a Series A warrant to purchase one share of common stock was $2.13. The public offering price of a Series B pre-funded warrant to purchase one share of common stock together with a Series A warrant to purchase one share of common stock was $2.12. The Series B pre-funded warrants had an exercise price of $0.01 per share, were immediately exercisable and do not expire. The Series A warrants have an exercise price of $3.04 per share, are exercisable for five years from the date of issuance, and are callable by the Company under certain circumstances.

 

On April 20, 2016, the Company closed on the underwritten public offering (the “April 2016 Underwritten Offering”) of 1,871,321 shares of its common stock and Series B pre-funded warrants to purchase 1,908,021 shares of common stock, plus the issuance of Series A warrants to purchase 3,779,342 shares of common stock, reflecting the exercise in full of the Underwriter’s over-allotment option. The gross proceeds of the offering amounted to approximately $8.0 million with net proceeds to the Company of approximately $7.2 million.

 

Warrant Restructuring

 

On April 13, 2016, the Company entered into an exchange and amendment agreement (the “Warrant Restructuring Agreement”). Pursuant to the Warrant Restructuring Agreement, the Company agreed with the holders of 2015 Series A warrants that upon the consummation of the 2016 Underwritten Offering, the exercise price of the 2015 Series A warrants would be reduced to the public offering price per share of the shares of common stock sold in this offering and that the warrants would be amended such that the exercise price would no longer be subject to adjustment in connection with future equity offerings we may undertake. In consideration of this amendment, the Company agreed to issue to each of those holders a new warrant to purchase an additional number of shares of common stock equal to twice the number of shares of common stock underlying the 2015 Series A Warrants held by them (the “Incremental Series A Warrants”). As a result, the 2015 Series A warrants and the Incremental Series A Warrants have an exercise price equal to $2.13 (the public offering price of the shares of common stock sold in the 2016 Underwritten Offering).

 

 10 

 

 

2016 Reverse Stock Split and Recapitalization

 

At a special meeting held on February 8, 2016, the Company’s stockholders approved an amendment to the Company’s certificate of incorporation to effect a reverse split of the Company’s common stock at a ratio between 1:5 to 1:10 in order to ensure that adequate authorized but unissued shares would be available for anticipated future financings, and to satisfy requirements for the continued listing of the Company’s common stock on the NASDAQ Capital Market. In addition, the proposal approved by the stockholders provided that if the reverse split was effected, the number of shares of common stock that the Company is authorized to issue remained unchanged at 40,000,000. The Company’s stockholders further authorized the board of directors to determine the ratio at which the reverse split would be effected by filing an appropriate amendment to the Company’s certificate of incorporation. The board of directors authorized the ratio of the reverse split on February 24, 2016, and effective at the close of business on March 4, 2016, the Company’s certificate of incorporation was amended to effect a 1-for-10 reverse split of the Company’s common stock (the “2016 Reverse Split”). All share and per share numbers included in these consolidated financial statements give effect to the 2016 Reverse Split.

 

Common Stock Warrants

 

The following table summarizes information with regard to outstanding warrants to purchase common stock as of March 31, 2017.

 

Offering  Number of Shares
 Issuable Upon
Exercise of
Outstanding
Warrants		   Exercise
Price		   Expiration Date
            
November 2016 Public Offering Series C   4,176,850   $1.50   November 29, 2021
April 2016 Underwritten Registered Series A   3,626,942   $3.04   April 20,2021
October 2015 Incremental Series A   300,006   $2.13   October 20,2021
October 2015 Private Placement Series A   86,365   $2.13   April 1, 2021
October 2015 Offering – Placement Agent   3,750   $28.30   October 1, 2020
August 2014 Public Offering (1)   504,019   $46.80   August 20, 2019
February 2013 Public Offering (1)   38,750   $1.50(2)  February 20, 2018
February 2013 Public Offering – Placement Agents   3,854   $125.00   February 4, 2018
November 2012 Private Placement   5,000   $250.00   November 2, 2017
June 2012 Public Offering   14,910   $250.00   June 13, 2017
Total   8,760,446         

 

(1)These warrants have a certain type of cash settlement feature or their exercise prices for which the warrant may be exercised are subject to adjustment for “down-rounds” and the warrants have been accounted for as derivative instruments as described in Note 3, with the exception of 9,704 warrants issued in August 2014.
(2)Due to the issuance of common stock at $1.50 per share as part of the November 2016 Underwritten Offering, the remaining outstanding warrants issued as part of the February 2013 Public Offering were adjusted to reflect the revised exercise price of $1.50 each.

 

Reserved Shares

 

The following shares were reserved for future issuance upon exercise of stock options, preferred stock conversions and warrants:

 

   March 31,
2017		   December 31,
 2016		 
         
Warrants   8,760,446    10,716,952 
Preferred stock   —    1,133,339 
Stock options   508,733    471,433 
Total number of shares reserved for future issuance   9,269,179    12,321,724 

 

 11 

 

 

4. NOTES PAYABLE

 

During the quarter ended March 31, 2017, the two loans with initial principal amounts totaling $450,000 from the Wisconsin Economic Development Corporation, dated September 15, 2010, were paid in full.

 

5. STOCK-BASED COMPENSATION

 

Accounting for Stock-Based Compensation

The following table summarizes amounts charged to expense for stock-based compensation related to employee and director stock option grants and recorded in connection with stock options granted to non-employee consultants:

 

   Three Months Ended
March 31,		 
   2017   2016 
         
Employee and director stock option grants:          
Research and development  $16,648   $11,035 
General and administrative   149,026    92,249 
    165,674    103,284 
           
Non-employee consultant stock option grants:          
Research and development   —    (366)
    —    (366)
           
Total stock-based compensation  $165,674   $102,918 

 

Assumptions Used In Determining Fair Value

 

Valuation and amortization method. The fair value of each stock award is estimated on the grant date using the Black-Scholes option-pricing model.  The estimated fair value of employee stock options is amortized to expense using the straight-line method over the vesting period. The estimated fair value of the non-employee options is amortized to expense over the period during which a non-employee is required to provide services for the award (usually the vesting period).

 

Volatility. The Company estimates volatility based on an average of (1) the Company’s historical volatility since its common stock has been publicly traded and (2) review of volatility estimates of publicly held drug development companies with similar market capitalizations.

 

Risk-free interest rate. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant commensurate with the expected term assumption.

 

Expected term. The expected term of stock options granted is based on an estimate of when options will be exercised in the future. The Company applied the simplified method of estimating the expected term of the options, as described in the SEC’s Staff Accounting Bulletins 107 and 110, as the historical experience is not indicative of the expected behavior in the future. The expected term, calculated under the simplified method, is applied to groups of stock options that have similar contractual terms. Using this method, the expected term is determined using the average of the vesting period and the contractual life of the stock options granted. The Company applied the simplified method to non-employees who have a truncation of term based on termination of service and utilizes the contractual life of the stock options granted for those non-employee grants which do not have a truncation of service.

 

Forfeitures. The Company records stock-based compensation expense only for those awards that are expected to vest. A forfeiture rate is estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from initial estimates. An annual forfeiture rate of 2% was applied to all unvested options for employees and directors, respectively, for the three months ended March 31, 2017 and for the year ended December 31, 2016.  Ultimately, the actual expense recognized over the vesting period will be for only those shares that vest.

 

 

 12 

 

 

Exercise prices for all grants made during the three months ended March 31, 2017 were equal to the market value of the Company’s common stock on the date of grant. There were no stock option grants during the three months ended March 31, 2016.

 

Stock Option Activity

 

A summary of stock option activity is as follows:

 

   Number of
Shares Issuable
Upon Exercise
of Outstanding
Options		   Weighted
Average
Exercise Price		   Weighted
Average
Remaining
Contracted
Term in
Years		   Aggregate
Intrinsic
Value		 
Outstanding at December 31, 2016   471,433   $7.59           
Granted   37,300   $2.18           
Expired   —   $—           
Forfeited   —   $—           
Outstanding at March 31, 2017   508,733   $7.19           
                     
Vested, March 31, 2017   104,106   $19.84    8.70   $54,579 
Unvested, March 31, 2017   404,627   $3.94    9.17   $167,134 
Exercisable at March 31, 2017   104,106   $19.84    8.70   $54,579 

 

The aggregate intrinsic value of options outstanding is calculated based on the positive difference between the estimated per-share fair value of common stock at the end of the respective period and the exercise price of the underlying options.  There have been no option exercises to date. Shares of common stock issued upon the exercise of options are from authorized but unissued shares.

 

As of March 31, 2017, there was approximately $950,882 of total unrecognized compensation cost related to unvested stock-based compensation arrangements.  Of this total amount, the Company expects to recognize approximately $372,648, $391,798, $186,079, and $357 during 2017, 2018, 2019 and 2020, respectively. The Company’s expense estimates are based upon the expectation that all unvested options will vest in the future, less the forfeiture rate discussed above. The weighted-average grant-date fair value of vested and unvested options outstanding at March 31, 2017 was $14.95 and $3.20, respectively.

 

6.  INCOME TAXES

 

The Company accounts for income taxes in accordance with the liability method of accounting. Deferred tax assets or liabilities are computed based on the difference between the financial statement and income tax basis of assets and liabilities, and net operating loss carryforwards, (NOLs) using the enacted tax rates. Deferred income tax expense or benefit is based on changes in the asset or liability from period to period. The Company did not record a provision or benefit for federal, state or foreign income taxes for the three months ended March 31, 2017 or 2016 because the Company has experienced losses on a tax basis since inception. Because of the limited operating history, continuing losses and uncertainty associated with the utilization of the NOLs in the future, management has provided a full allowance against the value of its gross deferred tax assets.

 

The Company also accounts for the uncertainty in income taxes related to the recognition and measurement of a tax position taken or expected to be taken in an income tax return. The Company follows the applicable accounting guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition related to the uncertainty in income tax positions. No uncertain tax positions have been identified.

 

 13 

 

  

7. NET INCOME (LOSS) PER SHARE

 

Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. Diluted net income per share for the three months ended March 31, 2016 is computed by dividing net income by the sum of the weighted average number of shares of common stock and the dilutive potential common stock equivalents then outstanding.  Potential common stock equivalents consist of stock options and warrants. Since there is a net loss attributable to common stockholders for the three months ended March 31, 2017, the inclusion of common stock equivalents in the computation for that period would be antidilutive.

 

The following potentially dilutive securities have been excluded from the computation of diluted net income (loss) per share since their inclusion would be antidilutive:

 

   Three Months Ended March 31, 
   2017   2016 
Warrants   8,760,446    782,782 
Stock options   508,733    68,582 

 

8.  COMMITMENTS AND CONTINGENCIES

 

The Company is involved in legal matters and disputes in the ordinary course of business. We do not anticipate that the outcome of such matters and disputes will materially affect the Company’s financial statements.

 

Item 2.     Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Forward-Looking Statements

 

This quarterly report on Form 10-Q includes forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, which we refer to as the Exchange Act. For this purpose, any statements contained herein regarding our strategy, future operations, financial position, future revenues, projected costs, prospects, plans and objectives of management, other than statements of historical facts, are forward-looking statements. The words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “may,” “plans,” “projects,” “will,” “would” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. We cannot guarantee that we actually will achieve the plans, intentions or expectations disclosed in our forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those disclosed in the forward-looking statements we make. These important factors include our significant accounting estimates, such as those for amounts due to clinical research organizations, and clinical investigators and the risk factors set forth in our annual report on Form 10-K and in Part II below under the caption “Risk Factors”. Although we may elect to update forward-looking statements in the future, we specifically disclaim any obligation to do so, even if our estimates change, and readers should not rely on those forward-looking statements as representing our views as of any date subsequent to the date of this quarterly report.

 

Overview

 

Cellectar Biosciences, Inc. (the Company) is a clinical stage biopharmaceutical company focused on the development of targeted phospholipid drug conjugates (PDCs) for the treatment of cancer. The Company’s research and development program is based on its proprietary PDC cancer targeting delivery platform. The delivery platform possesses the potential for the discovery and development of a broad range of cancer targeting agents. The Company’s pipeline is comprised of pre-clinical and clinical product candidates including radiotherapeutic and chemotherapeutic PDC’s. The Company’s research and development resources are focused on the clinical advancement of its therapeutic PDC’s.

 

Our Company’s core strategy is to leverage our industry leading PDC, proprietary cancer targeting delivery platform to generate capital, supplement internal resources and accelerate and broaden product candidate clinical development through strategic asset acquisitions and research collaborations.

 

Our shares are listed on the Nasdaq® Capital Market under the symbol CLRB; prior to August 15, 2014, our shares were quoted on the OTCQX® marketplace, and prior to February 12, 2014 were quoted under the symbol NVLT.

 

 14 

 

 

Our PDC platform is based on our cancer-targeting and delivery technology which provides selective delivery of a diverse range of oncologic payloads to cancer cells and cancer stem cells. By linking various drug payloads to our proprietary phospholipid ether cancer-targeting vehicle, we believe we can create PDCs with the potential to provide highly targeted delivery of chemotherapeutic and radiotherapeutic payloads to a broad range of cancers. As a result, our PDC platform has the potential to improve the therapeutic indices of drug payloads and enhance or maintain efficacy while minimizing the off-target and toxic side effects that frequently occur with typical cancer therapies. The Company is currently focused on the development of its lead therapeutic product candidate, CLR 131. Additionally, the Company is executing the pre-clinical evaluation and development of its CLR CTX Chemotherapeutic PDC program with both internal and external resources.

 

·CLR 131 is a small-molecule, cancer-targeting radiotherapeutic PDC that is designed to deliver cytotoxic (cell-killing) radiation directly and selectively to cancer cells and cancer stem cells. CLR 131 is our lead therapeutic PDC product candidate and is currently being evaluated in both Phase 1 and Phase 2 clinical studies. The Phase 1 clinical study is a standard three by three dose escalation safety study in patients with relapse or refractory multiple myeloma. Multiple myeloma is the second most common hematologic cancer and an incurable cancer of plasma cells. This cancer type was selected for clinical, regulatory and commercial rationales, including multiple myeloma’s highly radiosensitive nature, and continued unmet medical need in the relapse/refractory setting. The primary goals of the Phase 1 study are to assess the compound’s safety and tolerability in patients with relapsed or refractory multiple myeloma. Secondary objectives include establishment of a recommended Phase 2 dose, both with and without dexamethasone, as well as an assessment of therapeutic activity, including surrogate efficacy markers, progression free survival (PFS) and overall survival. The Investigational New Drug (IND) application was accepted by the U.S. Food and Drug Administration (FDA) in March 2014. In December 2014, the FDA granted orphan drug designation for CLR 131 for the treatment of multiple myeloma. The Phase 1 study was initiated in April 2015 and we announced favorable safety results from the first patient cohort in January 2016. The study’s Data Monitoring Committee (DMC), unanimously agreed to allow an increase in the dose of CLR 131 by 50% and advancement into the second cohort. The DMC reviewed Cohort 2 patient safety data in September 2016, and unanimously agreed to an increase in the dose by 33% and advancement to Cohort 3. In February 2017, the DMC unanimously determined the safety profile was again favorable in Cohort 3 and that it was acceptable to advance into Cohort 4 with an increase in dose by 20%. Surrogate markers of efficacy, including M protein, Free Light Chain (FLC), Progression Free Survival (PFS), and Overall Survival (OS), are also captured as secondary objectives of this Phase 1 study. In July 2016, the Company was awarded a $2,000,000 National Cancer Institute Fast-Track Small Business Innovation Research (SBIR) grant to further advance CLR 131. The funds are supporting a Phase 2 study the Company initiated in March 2017 to further define the clinical benefits of CLR 131 in multiple myeloma and other rare hematologic malignancies.

 

·The Company is exploring the creation of additional PDCs ranging from newly discovered to well-characterized chemotherapeutic payloads under its CLR CTX Chemotherapeutic PDC program. The objective of our CTX program is to develop PDC chemotherapeutics through conjugation of our delivery vehicle and non-targeted anti-cancer agents to improve therapeutic indices and expand potential indications through the targeted delivery of chemotherapeutic payloads. Initial CTX product candidates include CLR 1601-PTX, CLR 1602-PTX and CLR 1603-PTX; all are small-molecule, cancer-targeting chemotherapeutics in pre-clinical research. These PDCs are designed to selectively deliver paclitaxel, a chemotherapeutic payload to cancer cells and cancer stem cells increasing the therapeutic index of paclitaxel as a monotherapy. Each of our paclitaxel PDC’s have been evaluated in vitro to demonstrate formulation stability and CLR 1602-PTX is currently being studied in vivo to further explore the PDC’s cancer targeting selectivity. In December of 2015, the Company entered into a research collaboration for our PDC technology with Pierre Fabre laboratories, the third largest French pharmaceutical company. The objective of the research collaboration is to co-design a library of PDC’s employing Pierre Fabre’s chemotherapeutics in combination with our proprietary cancer targeting delivery vehicle. The newly developed PDC’s may provide enhanced therapeutic indices to otherwise highly potent, non-targeted payloads through the targeted delivery to cancer cells provided by our cancer targeted delivery vehicle.

 

·CLR 125 is a cancer-targeting radiotherapeutic currently under pre-clinical investigation for the treatment of micrometastatic disease. Similar to CLR 131, the selective uptake and retention of CLR 125 has been observed in malignant tissues during pre-clinical studies. Preclinical evaluation of this molecule was completed in June 2016 as part of the Phase 1 portion of an NCI SBIR award and demonstrated favorable biodistribution, tolerability, and dose response.

 

The Company’s product pipeline also includes a diagnostic imaging agent, CLR 124, a Phase 2-ready asset, as well as our 1500 series of optical imaging agents, including 1502, a Phase 1-ready asset. Although these are intriguing and potentially clinically useful compounds, at this time the Company has prioritized the development of its therapeutic assets.

 

 15 

 

 

We believe our PDC platform has potential to provide targeted delivery of a diverse range of oncologic payloads, as exemplified by the product candidates listed above, that may result in improvements upon current standard of care (SOC) for the treatment of a broad range of human cancers.

 

Results of Operations

 

Research and development expense.  Research and development expense consists of costs incurred in identifying, developing and testing, and manufacturing product candidates, which primarily include salaries and related expenses for personnel, costs of our research and manufacturing facility, cost of manufacturing materials and contract manufacturing fees paid to contract research organizations, fees paid to medical institutions for clinical trials, and costs to secure intellectual property. The Company analyzes its research and development expenses based on four categories as follows: clinical projects, preclinical projects, chemistry and manufacturing costs, and general fixed and overhead costs that are not allocated to the functional project costs, including personnel costs, facility costs, related overhead costs and patent costs.

 

General and administrative expense.  General and administrative expense consists primarily of salaries and other related costs for personnel in executive, finance and administrative functions.  Other costs include insurance, costs for public company activities, investor relations, directors’ fees and professional fees for legal and accounting services.

 

Three Months Ended March 31, 2017 and 2016

 

Research and Development. Research and development expense for the three months ended March 31, 2017 was approximately $1,857,000 (composed of $501,000 in clinical project costs, $91,000 of manufacturing and related costs and $1,265,000 in general unallocated research and development costs) compared to approximately $1,039,000 (composed of $188,000 in clinical project costs, $43,000 of preclinical project costs, $74,000 of manufacturing and related costs and $734,000 in general unallocated research and development costs) for the three months ended March 31, 2016. The overall increase in research and development expense of approximately $818,000, or 79%, was due primarily to an increase of approximately $256,000 in contract research; an increase of approximately $352,000 related to contract manufacturing and supply costs; an increase in consulting fees of approximately $160,000, and an increase in equipment and building repairs and maintenance of approximately $20,000, partially offset by a decrease in personnel costs of approximately $53,000 and a reduction in reimbursed costs related to the SBIR study of approximately $39,000. More generally, the spending increases in this category are all related to the hematologic malignancies Phase 2 trial that was initial in the fourth quarter of 2016.

 

General and Administrative. General and administrative expense for the three months ended March 31, 2017 was approximately $955,000 compared to approximately $961,000 in the three months ended March 31, 2016. While largely consistent between periods, the approximately $6,000 or 1% decrease was due to a shift in expense composition; primarily increased personnel costs of approximately $132,000 offset by a decrease in accounting fees of approximately $29,000; a decrease in public company expenses of approximately $57,000; and a decrease in consulting and marketing fees of approximately $37,000.

 

Gain (Loss) on Derivative Warrants. We recorded a loss on derivative warrants of approximately $83,000 in the three months ended March 31, 2017, as compared to a gain of approximately $2,825,000 in the three months ended March 31, 2016. These amounts represent the change in fair value (resulting primarily from changes in the Company’s stock price as well as a reduction in term, during the respective periods), of outstanding warrants which are classified as liabilities because they contain a certain type of cash settlement feature, “down-round” anti-dilution provisions whereby the number of shares for which the warrants are exercisable and/or the exercise price of the warrants is subject to change in the event of certain issuances of stock at prices below the then-effective exercise prices of the warrants. The fluctuations we experienced in historical periods have been substantially reduced as a result of the renegotiation or extinguishment of a significant portion of the liability-classified warrants.

 

Interest income, net. Interest income, net, for the three months ended March 31, 2017 was relatively consistent with that recorded in the three months ended March 31, 2016.

 

 16 

 

 

Liquidity and Capital Resources

 

We have financed our operations since inception primarily through the sale of equity and debt securities. As of March 31, 2017, we had approximately $11,238,000 in cash and cash equivalents. To that date, we have raised capital aggregating approximately $167 million.

 

During the three months ended March 31, 2017, we reported net loss of approximately $2,891,000, while using approximately $2,987,000 in cash in operations. The net loss included an approximately $83,000 loss on the revaluation of derivative warrants, approximately $166,000 in stock-based compensation expense and approximately $87,000 in depreciation and amortization expense. After adjustment for these non-cash items, changes in working capital used approximately $431,000 of cash, of which $230,000 was the result of the timing of payments of accounts payable and accrued expenses and the remainder was an increase in prepaid and other assets of approximately $201,000. Also during this period, Series C warrants representing 1,956,506 shares of common stock were exercised by the holders, for proceeds of $2,934,759.

 

The accompanying consolidated financial statements have been prepared on a basis that assumes that we will continue as a going concern and that contemplates the continuity of operations, realization of assets and the satisfaction of liabilities and commitments in the normal course of business. During the three months ended March 31, 2017, we generated an operating loss of approximately $2,812,000 and we expect that we will continue to generate operating losses for the foreseeable future. At March 31, 2017, our consolidated cash balance was approximately $11,238,000.

 

On November 29, 2016, the Company closed on an underwritten public offering (the “November 2016 Underwritten Offering”) of 1.6 million shares of common stock, 68 shares of Series A preferred stock convertible into 4,533,336 shares of common stock, and Series C warrants to purchase 6.3 million shares of common stock, reflecting the exercise in full of the Underwriter’s over-allotment option. The gross proceeds of the offering amounted to $9.2 million with net proceeds to the Company of approximately $8.3 million.

 

On April 20, 2016, the Company closed on its underwritten public offering of approximately 1.87 million shares of its common stock and Series B pre-funded warrants to purchase approximately 1.91 million shares of common stock, plus the issuance of Series A warrants to purchase approximately 3.78 million shares of common stock, reflecting the exercise in full of the Underwriter’s over-allotment option (the “April 2016 Underwritten Offering”). The gross proceeds of the offering amounted to approximately $8.0 million with net proceeds to the Company of approximately $7.2 million.

 

We believe our March 31, 2017 cash balance of approximately $11,238,000 is adequate to fund operations into the second quarter of 2018. Our ability to execute our operating plan beyond that time depends on our ability to obtain additional funding via the sale of equity and/or debt securities, a strategic transaction or otherwise. We have, in the past, successfully completed multiple rounds of financings, but due to market conditions and other factors, including our development stage, the proceeds we have been able to secure have been less than the amounts we sought to obtain. We plan to actively pursue all available financing alternatives; however, we have not entered into negotiations for any such transactions and there can be no assurance that we will obtain the necessary funding. Other than the uncertainties regarding our ability to obtain additional funding, there are currently no known trends, demands, commitments, events or uncertainties that are likely to materially affect our liquidity.

 

Item 4.    Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures. Based on our management’s evaluation (with the participation of our principal executive officer and principal financial officer), as of March 31, 2017, our management has concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) were effective to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms.

 

Changes in internal control over financial reporting. There have not been any significant changes in the Company’s internal control of financial reporting.

 

The Chief Executive Officer and the Audit Committee perform significant roles in ensuring the accuracy and completeness of our financial reporting and the effectiveness of our disclosure controls and procedures. We have not identified any changes that occurred during the Company’s fiscal quarter ended March 31, 2017 that materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

Important Considerations. Any system of controls, however well designed and operated, can provide only reasonable, and not absolute assurance that the objectives of the system are met. In addition, the design of any control system is based in part on certain assumptions about the likelihood of future events. The effectiveness of our disclosure controls and procedures is subject to various inherent limitations, including cost limitations, judgments used in decision making, assumptions about the likelihood of future events, the soundness of our systems, the possibility of human error, and the risk of fraud. Because of these and other inherent limitations of control systems, there can be no assurance that any system of disclosure controls and procedures will be successful in achieving its stated goals, including but not limited to preventing all errors or fraud or in making all material information known in a timely manner to the appropriate levels of management, under all potential future conditions, regardless of how remote.

 

 17 

 

 

PART II. OTHER INFORMATION

 

Item 1. Legal Proceedings

 

None.

 

Item 1A. Risk Factors

 

We will require additional capital in order to continue our operations, and may have difficulty raising additional capital.

 

We expect that we will continue to generate significant operating losses for the foreseeable future. At March 31, 2017, our consolidated cash balance was approximately $11.2 million. We believe our cash balance at March 31, 2017, is adequate to fund operations into the second quarter of 2018. We will require additional funds to conduct research and development, establish and conduct clinical and preclinical trials, establish commercial-scale manufacturing arrangements and provide for the marketing and distribution of our products. Our ability to execute our operating plan depends on our ability to obtain additional funding via the sale of equity and/or debt securities, a strategic transaction or otherwise. We plan to actively pursue financing alternatives. However, there can be no assurance that we will obtain the necessary funding in the amounts we seek or that it will be available on a timely basis or upon terms acceptable to us. If we obtain capital by issuing debt or preferred stock, the holders of such securities would likely obtain rights that are superior to those of holders of our common stock.

 

Our capital requirements and our ability to meet them depend on many factors, including:

 

  · the number of potential products and technologies in development;
  · continued progress and cost of our research and development programs;
  · progress with preclinical studies and clinical trials;
  · the time and costs involved in obtaining regulatory clearance;
  · costs involved in preparing, filing, prosecuting, maintaining and enforcing patent claims;
  · costs of developing sales, marketing and distribution channels and our ability to sell our drugs;
  · costs involved in establishing manufacturing capabilities for clinical trial and commercial quantities of our drugs;
  · competing technological and market developments;
  · market acceptance of our products;
  · costs for recruiting and retaining management, employees and consultants;
  · costs for educating physicians regarding the application and use of our products;
  · whether we are able to maintain our listing on a national exchange;
  · uncertainty and economic instability resulting from terrorist acts and other acts of violence or war; and
  · the condition of capital markets and the economy generally, both in the U.S. and globally.

 

We may consume available resources more rapidly than currently anticipated, resulting in the need for additional funding sooner than expected. We may seek to raise any necessary additional funds through the issuance of warrants, equity or debt financings or executing collaborative arrangements with corporate partners or other sources, which may be dilutive to existing stockholders or have a material effect on our current or future business prospects. In addition, in the event that additional funds are obtained through arrangements with collaborative partners or other sources, we may have to relinquish economic and/or proprietary rights to some of our technologies or products under development that we would otherwise seek to develop or commercialize by ourselves. If we cannot secure adequate financing when needed, we may be required to delay, scale back or eliminate one or more of our research and development programs or to enter into license or other arrangements with third parties to commercialize products or technologies that we would otherwise seek to develop ourselves and commercialize ourselves. In such an event, our business, prospects, financial condition, and results of operations may be adversely affected.

 

We will require additional funds to conduct research and development, establish and conduct preclinical and clinical trials, establish commercial-scale manufacturing arrangements and provide for the marketing and distribution of our products. Our ability to execute our operating plan depends on our ability to obtain additional funding via the sale of equity and/or debt securities, a strategic transaction or otherwise.

 

We have incurred net losses and negative cash flows since inception. We currently have no product revenues, and may not succeed in developing or commercializing any products that will generate product or licensing revenues. We do not expect to have any products on the market for several years. Our primary activity to date has been research and development and conducting clinical trials. Development of our product candidates requires a process of preclinical and clinical testing, during which our product candidates could fail. We may not be able to enter into agreements with one or more companies experienced in the manufacturing and marketing of therapeutic drugs and, to the extent that we are unable to do so, we may not be able to market our product candidates. Whether we achieve profitability or not will depend on our success in developing, manufacturing, and marketing our product candidates. We have experienced net losses and negative cash flows from operating activities since inception and we expect such losses and negative cash flows to continue for the foreseeable future. As of March 31, 2017, we had a stockholders’ equity of approximately $13,749,000. The operating loss for the three months ended March 31, 2017 was approximately $2,812,000, and we may never achieve profitability.

 

 18 

 

 

Item 6. Exhibits

 

            Incorporation by Reference
Exhibit
No.		   Description   Filed with
this
Form 10-Q		   Form   Filing Date   Exhibit
No.
                     
31.1   Certification of chief executive officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002   X            
31.2   Certification of chief financial officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002   X            
32.1   Certification of chief executive officer and chief financial officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002   X            
101   Interactive Data Files   X            

 

 19 

 

 

SIGNATURES

 

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  CELLECTAR BIOSCIENCES, INC.
   
     
Date:  May 11, 2017 By: /s/ James V. Caruso
    James V. Caruso
    President and Chief Executive Officer

 

 20 

 

 EX-31.1 2 v466189_ex31-1.htm EXHIBIT 31.1

 

EXHIBIT 31.1

 

I, JAMES V. CARUSO, certify that:

 

1.I have reviewed this quarterly report on Form 10-Q of Cellectar Biosciences, Inc., a Delaware Corporation;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 11, 2017

 

/s/ James V. Caruso  
James V. Caruso  
President and Chief Executive Officer (Principal Executive Officer)  

 

 

 

 EX-31.2 3 v466189_ex31-2.htm EXHIBIT 31.2

 

EXHIBIT 31.2

 

I, CHAD KOLEAN, certify that:

 

1.I have reviewed this quarterly report on Form 10-Q of Cellectar Biosciences, Inc., a Delaware Corporation;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 11, 2017

 

  /s/ Chad Kolean  
Chad Kolean  
Chief Financial Officer (Principal Financial and Accounting Officer)  

 

 

 

 EX-32.1 4 v466189_ex32-1.htm EXHIBIT 32.1

 

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO
18 U.S.C. § 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q of Cellectar Biosciences, Inc. (the “Company”) for the quarter ended March 31, 2017, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), we, James V. Caruso, President and Chief Executive Officer of the Company, and Chad J. Kolean, Vice President, Chief Financial Officer and Treasurer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to our knowledge, that:

 

1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

/s/ James V. Caruso  
James V. Caruso  
President and Chief Executive Officer (Principal Executive Officer)  
Date: May 11, 2017  
   
/s/ Chad Kolean  
Chad Kolean  
Chief Financial Officer (Principal Financial and Accounting Officer)  
Date: May 11, 2017  

 

 

 

 EX-101.INS 5 clrb-20170331.xml XBRL INSTANCE DOCUMENT 0001279704 2016-01-01 2016-03-31 0001279704 2016-01-01 2016-12-31 0001279704 2017-01-01 2017-03-31 0001279704 2016-02-01 2016-02-08 0001279704 2016-02-08 0001279704 2016-03-01 2016-03-04 0001279704 2017-03-31 0001279704 2017-05-08 0001279704 2016-12-31 0001279704 2015-12-31 0001279704 2016-03-31 0001279704 us-gaap:ConvertibleDebtMember us-gaap:WarrantMember 2017-01-01 2017-03-31 0001279704 us-gaap:ConvertibleDebtMember us-gaap:StockOptionMember 2017-01-01 2017-03-31 0001279704 us-gaap:ConvertibleDebtMember us-gaap:WarrantMember 2016-01-01 2016-03-31 0001279704 us-gaap:ConvertibleDebtMember us-gaap:StockOptionMember 2016-01-01 2016-03-31 0001279704 clrb:EmployeeAndDirectorStockOptionMember us-gaap:ResearchAndDevelopmentExpenseMember 2017-01-01 2017-03-31 0001279704 clrb:EmployeeAndDirectorStockOptionMember us-gaap:GeneralAndAdministrativeExpenseMember 2017-01-01 2017-03-31 0001279704 clrb:EmployeeAndDirectorStockOptionMember us-gaap:ResearchAndDevelopmentExpenseMember 2016-01-01 2016-03-31 0001279704 clrb:EmployeeAndDirectorStockOptionMember us-gaap:GeneralAndAdministrativeExpenseMember 2016-01-01 2016-03-31 0001279704 us-gaap:ResearchAndDevelopmentExpenseMember clrb:NonEmployeeConsultantStockOptionMember 2017-01-01 2017-03-31 0001279704 us-gaap:ResearchAndDevelopmentExpenseMember clrb:NonEmployeeConsultantStockOptionMember 2016-01-01 2016-03-31 0001279704 us-gaap:CommonStockMember clrb:LadenburgThalmannMember 2016-11-01 2016-11-23 0001279704 us-gaap:SeriesAPreferredStockMember clrb:LadenburgThalmannMember 2016-11-01 2016-11-23 0001279704 us-gaap:CommonStockMember clrb:LadenburgThalmannMember us-gaap:OverAllotmentOptionMember 2016-11-01 2016-11-23 0001279704 us-gaap:SeriesAPreferredStockMember clrb:LadenburgThalmannMember 2016-11-23 0001279704 clrb:LadenburgThalmannMember 2016-11-23 0001279704 clrb:LadenburgThalmannMember 2016-11-01 2016-11-23 0001279704 clrb:LadenburgThalmannMember us-gaap:OverAllotmentOptionMember 2016-11-01 2016-11-23 0001279704 clrb:SeriesWarrantsMember clrb:LadenburgThalmannMember 2016-11-01 2016-11-23 0001279704 clrb:UnderwrittenOffering2016Member clrb:LadenburgThalmannMember 2016-11-01 2016-11-29 0001279704 clrb:LadenburgThalmannMember 2016-04-01 2016-04-15 0001279704 clrb:SeriesBPreFundedWarrantMember 2016-04-01 2016-04-15 0001279704 clrb:SeriesWarrantsMember 2016-04-15 0001279704 clrb:SeriesZConvertiblePreferredStockMember 2016-04-15 0001279704 us-gaap:OverAllotmentOptionMember clrb:SeriesPrefundedWarrantMember 2016-04-01 2016-04-15 0001279704 clrb:SeriesPrefundedWarrantMember 2016-04-01 2016-04-15 0001279704 clrb:SeriesBPreFundedWarrantMember 2016-04-15 0001279704 clrb:SeriesPrefundedWarrantMember 2016-04-15 0001279704 clrb:UnderwrittenOffering2016Member 2016-04-01 2016-04-20 0001279704 clrb:SeriesBPreFundedWarrantMember 2016-04-01 2016-04-20 0001279704 clrb:SeriesWarrantsMember 2016-04-01 2016-04-20 0001279704 clrb:UnderwrittenOffering2016Member 2016-04-13 0001279704 clrb:November2016PublicOfferingSeriesCMember 2017-03-31 0001279704 clrb:April2016UnderwrittenRegisteredSeriesMember 2017-03-31 0001279704 clrb:October2015IncrementalSeriesMember 2017-03-31 0001279704 clrb:October2015PrivatePlacementSeriesMember 2017-03-31 0001279704 clrb:October2015OfferingPlacementAgentMember 2017-03-31 0001279704 clrb:August2014PublicOfferingMember 2017-03-31 0001279704 clrb:February2013PublicOfferingMember 2017-03-31 0001279704 clrb:February2013PublicOfferingPlacementAgentsMember 2017-03-31 0001279704 clrb:NovemberPrivatePlacementMember 2017-03-31 0001279704 clrb:JunePublicOfferingMember 2017-03-31 0001279704 clrb:November2016PublicOfferingSeriesCMember 2017-01-01 2017-03-31 0001279704 clrb:April2016UnderwrittenRegisteredSeriesMember 2017-01-01 2017-03-31 0001279704 clrb:October2015IncrementalSeriesMember 2017-01-01 2017-03-31 0001279704 clrb:October2015PrivatePlacementSeriesMember 2017-01-01 2017-03-31 0001279704 clrb:October2015OfferingPlacementAgentMember 2017-01-01 2017-03-31 0001279704 clrb:August2014PublicOfferingMember 2017-01-01 2017-03-31 0001279704 clrb:February2013PublicOfferingMember 2017-01-01 2017-03-31 0001279704 clrb:February2013PublicOfferingPlacementAgentsMember 2017-01-01 2017-03-31 0001279704 clrb:NovemberPrivatePlacementMember 2017-01-01 2017-03-31 0001279704 clrb:JunePublicOfferingMember 2017-01-01 2017-03-31 0001279704 us-gaap:WarrantMember 2017-01-01 2017-03-31 0001279704 us-gaap:EmployeeStockOptionMember 2017-01-01 2017-03-31 0001279704 us-gaap:WarrantMember 2016-01-01 2016-12-31 0001279704 us-gaap:EmployeeStockOptionMember 2016-01-01 2016-12-31 0001279704 us-gaap:PreferredStockMember 2017-01-01 2017-03-31 0001279704 us-gaap:PreferredStockMember 2016-01-01 2016-12-31 0001279704 us-gaap:FairValueInputsLevel1Member clrb:February2013PublicOfferingWarrantsMember 2017-03-31 0001279704 us-gaap:FairValueInputsLevel1Member 2017-03-31 0001279704 us-gaap:FairValueInputsLevel2Member clrb:February2013PublicOfferingWarrantsMember 2017-03-31 0001279704 us-gaap:FairValueInputsLevel2Member 2017-03-31 0001279704 us-gaap:FairValueInputsLevel3Member clrb:February2013PublicOfferingWarrantsMember 2017-03-31 0001279704 us-gaap:FairValueInputsLevel3Member 2017-03-31 0001279704 clrb:February2013PublicOfferingWarrantsMember 2017-03-31 0001279704 us-gaap:FairValueInputsLevel1Member clrb:WarrantTwoMember 2017-03-31 0001279704 us-gaap:FairValueInputsLevel2Member clrb:WarrantTwoMember 2017-03-31 0001279704 us-gaap:FairValueInputsLevel3Member clrb:WarrantTwoMember 2017-03-31 0001279704 clrb:WarrantTwoMember 2017-03-31 0001279704 us-gaap:FairValueInputsLevel1Member clrb:February2013PublicOfferingWarrantsMember 2016-12-31 0001279704 us-gaap:FairValueInputsLevel1Member 2016-12-31 0001279704 us-gaap:FairValueInputsLevel2Member clrb:February2013PublicOfferingWarrantsMember 2016-12-31 0001279704 us-gaap:FairValueInputsLevel2Member 2016-12-31 0001279704 us-gaap:FairValueInputsLevel3Member clrb:February2013PublicOfferingWarrantsMember 2016-12-31 0001279704 us-gaap:FairValueInputsLevel3Member 2016-12-31 0001279704 clrb:February2013PublicOfferingWarrantsMember 2016-12-31 0001279704 us-gaap:FairValueInputsLevel1Member clrb:WarrantTwoMember 2016-12-31 0001279704 us-gaap:FairValueInputsLevel2Member clrb:WarrantTwoMember 2016-12-31 0001279704 us-gaap:FairValueInputsLevel3Member clrb:WarrantTwoMember 2016-12-31 0001279704 clrb:WarrantTwoMember 2016-12-31 0001279704 clrb:February2013PublicOfferingWarrantsMember 2013-02-28 0001279704 clrb:February2013PublicOfferingWarrantsMember 2014-02-01 2014-02-20 0001279704 clrb:August2014PublicOfferingWarrantsMember 2014-08-31 0001279704 us-gaap:SeriesAPreferredStockMember 2017-03-31 0001279704 us-gaap:SeriesAPreferredStockMember 2016-12-31 0001279704 clrb:TwoThousandThirteenWarrantsMember 2017-01-01 2017-03-31 0001279704 clrb:TwoThousandFifteenWarrantsMember 2017-01-01 2017-03-31 0001279704 us-gaap:FairValueInputsLevel3Member 2015-12-31 0001279704 us-gaap:FairValueInputsLevel3Member 2017-01-01 2017-03-31 0001279704 us-gaap:FairValueInputsLevel3Member 2016-01-01 2016-12-31 0001279704 clrb:TwoThousandThirteenWarrantsMember 2016-01-01 2016-12-31 0001279704 us-gaap:MinimumMember clrb:TwoThousandThirteenWarrantsMember 2016-01-01 2016-12-31 0001279704 us-gaap:MaximumMember clrb:TwoThousandThirteenWarrantsMember 2016-01-01 2016-12-31 0001279704 clrb:February2013PublicOfferingWarrantsMember 2016-05-01 2016-05-20 0001279704 clrb:February2013PublicOfferingWarrantsMember us-gaap:FairValueInputsLevel3Member 2016-05-20 0001279704 us-gaap:SeriesAPreferredStockMember 2017-01-01 2017-03-31 0001279704 clrb:SeriesCPreFundedWarrantMember 2017-01-01 2017-03-31 0001279704 clrb:August2014UnderwrittenOfferingMember 2017-03-31 0001279704 clrb:EmployeeAndDirectorStockOptionMember 2017-01-01 2017-03-31 0001279704 clrb:EmployeeAndDirectorStockOptionMember 2016-01-01 2016-03-31 0001279704 clrb:NonEmployeeConsultantStockOptionMember 2017-01-01 2017-03-31 0001279704 clrb:NonEmployeeConsultantStockOptionMember 2016-01-01 2016-03-31 0001279704 clrb:EmployeeMember 2017-01-01 2017-03-31 0001279704 clrb:EmployeeMember 2016-01-01 2016-12-31 0001279704 us-gaap:DirectorMember 2017-01-01 2017-03-31 0001279704 us-gaap:DirectorMember 2016-01-01 2016-12-31 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure 11238394 11444619 893185 693569 12186579 12193188 1423448 1444058 1675462 1675462 11872 11872 15297361 15324580 0 86591 1186092 1416433 209600 127125 2801 2727 1398493 1632876 145367 146583 4520 5249 149887 151832 1548380 1784708 0 875572 135 104 87427196 83451222 -73678350 -70787026 13748981 13539872 15297361 15324580 55000 55000 1039454 961254 2000708 -2000708 2824722 549 824563 2825271 1856880 955356 2812236 -2812236 -82475 3387 -2891324 -79088 86911 90773 165674 102918 -230341 -67256 199616 -55793 -2987437 -1818256 66301 0 -66301 0 655 588 2847513 -131160 -206225 -1949416 3857791 1908375 364 1467 0 594 0 69450 8760446 508733 782782 68582 16648 149026 11035 92249 0 -366 104106 404627 104106 19.84 3.94 19.84 54579 167134 54579 P8Y8M12D P9Y2M1D P8Y8M12D 471433 37300 0 7.59 2.18 0 508733 7.19 0 0 950882 800000 68 800000 4533356 66667 1.50 5333356 800000 1.50 66667 100000 9200000 8300000 1378364 1908021 3286385 492957 492957 2.13 2.12 0.01 3.04 1871321 1908021 3779342 8000000 7200000 2.13 40000000 8760446 4176850 3626942 300006 86365 3750 504019 38750 3854 5000 14910 1.5 3.04 2.13 2.13 28.3 46.8 1.5 125 250 250 2021-11-29 2021-04-20 2021-10-20 2021-04-01 2020-10-01 2019-08-20 2018-02-20 2018-02-04 2017-11-02 2017-06-13 9269179 12321724 8760446 508733 10716952 471433 0 1133339 0 0 0 160000 49600 49600 49600 0 160000 0 160000 0 0 0 100000 27125 27125 27125 0 100000 0 100000 82500 27500 494315 10-Q false 2017-03-31 2017 Q1 Cellectar Biosciences, Inc. 0001279704 --12-31 Smaller Reporting Company CLRB 13462170 0.00001 0.00001 0.00001 0.00001 7000 7000 0 17 0 17 40000000 40000000 13458170 13458170 10368325 10368325 -0.24 0.96 12010284 858107 -0.24 0.91 12010284 906381 1216 325 2934759 0 86591 60528 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="center"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><font style="FONT-SIZE: 10pt">1. NATURE OF BUSINESS, ORGANIZATION AND GOING CONCERN</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Cellectar Biosciences, Inc. (the &#8220;Company&#8221;) is a biopharmaceutical company developing compounds for the treatment and imaging of cancer. The Company&#8217;s headquarters are located in Madison, Wisconsin.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The Company is subject to a number of risks similar to those of other small pharmaceutical companies. Principal among these risks are dependence on key individuals, competition from substitute products and larger companies, the successful development and marketing of its products in a highly regulated environment and the need to obtain additional financing necessary to fund future operations.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <font style="FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The accompanying financial statements have been prepared on a basis that assumes that the Company will continue as a going concern and that contemplates the continuity of operations, realization of assets and the satisfaction of liabilities and commitments in the normal course of business. The Company has devoted substantially all of its efforts toward research and development and has, during the three months ended March 31, 2017, generated an operating loss of approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2,812,000</font>. The Company expects that it will continue to generate operating losses for the foreseeable future.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The Company believes that its cash balance at March 31, 2017 is adequate to fund operations at budgeted levels into second quarter 2018. The Company&#8217;s ability to execute its operating plan beyond second quarter 2018 depends on its ability to obtain additional funding via the sale of equity and/or debt securities, a strategic transaction or otherwise. The Company plans to continue to actively pursue financing alternatives, but there can be no assurance that it will obtain the necessary funding, raising substantial doubt about the Company&#8217;s ability to continue as a going concern within one year of the date these financial statements are issued. The accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The accompanying condensed consolidated balance sheet as of December 31, 2016 has been derived from audited financial statements. The accompanying unaudited condensed consolidated balance sheet as of March 31, 2017, the condensed consolidated statements of operations for the three months ended March 31, 2017 and 2016, the condensed consolidated statements of cash flows for the three months ended March 31, 2017 and 2016 and the related interim information contained within the notes to the condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;) for interim financial information and with the instructions, rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;) for interim financial information. Accordingly, they do not include all of the information and the notes required by U.S. GAAP for complete financial statements. In the opinion of management, the unaudited interim condensed consolidated financial statements reflect all adjustments which are of a nature necessary for the fair presentation of the Company&#8217;s consolidated financial position at March 31, 2017 and consolidated results of its operations for the three months ended March 31, 2017 and 2016, and its cash flows for the three months ended March 31, 2017 and 2016. The results for the three months ended March 31, 2017 are not necessarily indicative of future results.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">These unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and related notes thereto included in the Company&#8217;s Form 10-K for the fiscal year ended December 31, 2016, which was filed with the SEC on March 15, 2017.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><i><font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>Principles of Consolidation</font></i></b> <font style="FONT-SIZE: 10pt"> &#151; The consolidated financial statements include the accounts of the Company and the accounts of its wholly-owned subsidiary. All significant intercompany accounts and transactions have been eliminated.</font></div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><i><font style="FONT-SIZE: 10pt">&#160;</font></i></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><i><font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>Restricted Cash</font></i></b> <font style="FONT-SIZE: 10pt">&#151; The Company accounts for cash that is restricted for other than current operations as restricted cash. Restricted cash at March 31, 2017 and December 31, 2016 consisted of a certificate of deposit of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">55,000</font></font> required under the Company&#8217;s lease agreement for its Madison, Wisconsin facility.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><i><font style="FONT-SIZE: 10pt">&#160;</font></i></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><i><font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>Goodwill</font></i></b> <font style="FONT-SIZE: 10pt">&#151; Goodwill is not amortized, but is required to be evaluated for impairment annually or whenever events or changes in circumstances suggest that the carrying value of an asset may not be recoverable. The Company evaluates goodwill for impairment annually in the fourth fiscal quarter and additionally on an interim basis if an event occurs or there is a change in circumstances, such as a decline in the Company&#8217;s stock price or a material adverse change in the business climate, which would more likely than not reduce the fair value of the reporting unit below its carrying amount. No such event or change in circumstances occurred; therefore, no changes in goodwill were made during the three months ended March&#160;31, 2017 and 2016.</font></div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">In January 2017, the FASB issued ASU No. 2017-04, Simplifying the Test for Goodwill. The standard streamlines the methodology for calculating whether goodwill is impaired based upon whether the carrying amount of goodwill exceeds the reporting unit&#8217;s fair value. ASU 2017-04 applies to public business entities and those other entities that have goodwill reported in their financial statements and have not elected the private company alternative for the subsequent measurement of goodwill and is effective for annual and interim reporting periods beginning after December&#160;15, 2019, with early adoption permitted. The Company does not expect that the adoption of this standard will have a material effect on its financial statements.</font></div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><i><font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>Impairment of Long</font></i></b><font style="FONT-SIZE: 10pt">-<b><i>Lived Assets</i></b> &#151; Long-lived assets other than goodwill consist primarily of fixed assets, which we periodically evaluate for potential impairment. Whenever events or circumstances change, an assessment is made as to whether there has been an impairment in the value of long-lived assets by determining whether projected undiscounted cash flows generated by the applicable asset exceed its net book value as of the assessment date. No such event or change in circumstances occurred; therefore, no such impairment occurred during the three months ended March&#160;31, 2017 and 2016.</font></div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><i><font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>Stock-Based Compensation</font></i></b> <font style="FONT-SIZE: 10pt">&#151; The Company uses the Black-Scholes option-pricing model to calculate the grant-date fair value of stock option awards. The resulting compensation expense, net of expected forfeitures, for awards that are not performance-based is recognized on a straight-line basis over the service period of the award, which is generally three years for stock options. For stock options with performance-based vesting provisions, recognition of compensation expense, net of expected forfeitures, commences if and when the achievement of the performance criteria is deemed probable. The compensation expense, net of expected forfeitures, for performance-based stock options is recognized over the relevant performance period. Awards of stock that are not performance-based are valued at the fair market value on the date of the grant and are amortized over the service period of the award. Non-employee stock-based compensation is accounted for in accordance with the guidance of Financial Accounting Standards Board Accounting Standards Codification (&#8220;FASB ASC&#8221;) Topic 505, <i> Equity.&#160;</i> As such, the Company recognizes expense based on the estimated fair value of options granted to non-employees over their vesting period, which is generally the period during which services are rendered and deemed completed by such non-employees.</font></div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><i><font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>Fair Value of Financial Instruments</font></i></b> <font style="FONT-SIZE: 10pt">&#151; The guidance under FASB ASC Topic 825, <i> Financial Instruments</i>, requires disclosure of the fair value of certain financial instruments. Financial instruments in the accompanying financial statements consist of cash equivalents, accounts payable and long-term obligations.&#160; The carrying amount of cash equivalents and accounts payable approximate their fair value due to their short-term nature.&#160; The carrying value of remaining long-term obligations, including the current portion, approximates fair value because the fixed interest rate approximates current market interest rates available on similar instruments.</font></div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <font style="FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><i><font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>Derivative Instruments</font></i></b> <font style="FONT-SIZE: 10pt">&#151; The Company generally does not use derivative instruments to hedge exposures to cash flow or market risks.&#160; However, certain warrants to purchase common stock that do not meet the requirements for classification as equity, in accordance with the Derivatives and Hedging Topic of the FASB ASC, are classified as liabilities.&#160; In such instances, net-cash settlement is assumed for financial reporting purposes, even when the terms of the underlying contracts do not provide for a net-cash settlement. These warrants are considered derivative instruments because the agreements contain a certain type of cash settlement feature, &#8220;down-round&#8221; provisions whereby the number of shares for which the warrants are exercisable and/or the exercise price of the warrants is subject to change in the event of certain issuances of stock at prices below the then-effective exercise price of the warrants. The number of shares issuable under such warrants was <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 533,065</font></font> at March&#160;31, 2017 and December 31, 2016. The primary underlying risk exposure pertaining to the warrants is the change in fair value of the underlying common stock.&#160; Such financial instruments are initially recorded at fair value with subsequent changes in fair value recorded as a component of gain or loss on derivatives on the consolidated statements of operations in each reporting period. If these instruments subsequently meet the requirements for equity classification, the Company reclassifies the fair value to equity. At March&#160;31, 2017 and December 31, 2016, these warrants represented the only outstanding derivative instruments issued or held by the Company.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Leases</font></b> <font style="FONT-SIZE: 10pt">&#151; In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) which supersedes FASB ASC Topic 840, Leases (Topic 840) and provides principles for the recognition, measurement, presentation and disclosure of leases for both lessees and lessors. The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight-line basis over the term of the lease, respectively. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than twelve months regardless of classification. Leases with a term of twelve months or less will be accounted for similar to existing guidance for operating leases. The standard is effective for annual and interim periods beginning after December 15, 2018, with early adoption permitted upon issuance. The Company is currently evaluating the method of adoption and the impact of adopting ASU 2016-02 on its results of operations, cash flows and financial position.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 55000 55000 533065 533065 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><font style="FONT-SIZE: 10pt">2. FAIR VALUE</font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">In accordance with Fair Value Measurements and Disclosures Topic of the FASB ASC 820, the Company groups its financial assets and financial liabilities generally measured at fair value in three levels, based on the markets in which the assets and liabilities are traded and the reliability of the assumptions used to determine fair value.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; FONT: 10pt Times New Roman, Times, Serif" cellspacing="0" cellpadding="0"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 2%"> <div>&#160;</div> </td> <td style="WIDTH: 3%"> <div><font style="FONT-SIZE: 10pt;FONT-FAMILY:Symbol"> &#8901;</font></div> </td> <td style="WIDTH: 95%"> <div><font style="FONT-SIZE: 10pt">Level 1: Input prices quoted in an active market for identical financial assets or liabilities.</font></div> </td> </tr> <tr style="VERTICAL-ALIGN: top"> <td> <div>&#160;</div> </td> <td> <div><font style="FONT-SIZE: 10pt;FONT-FAMILY:Symbol"> &#8901;</font></div> </td> <td> <div><font style="FONT-SIZE: 10pt">Level 2: Inputs other than prices quoted in Level 1, such as prices quoted for similar financial assets and liabilities in active markets, prices for identical assets, and liabilities in markets that are not active or other inputs that are observable or can be corroborated by observable market data.</font></div> </td> </tr> <tr style="VERTICAL-ALIGN: top"> <td> <div>&#160;</div> </td> <td> <div><font style="FONT-SIZE: 10pt;FONT-FAMILY:Symbol"> &#8901;</font></div> </td> <td> <div><font style="FONT-SIZE: 10pt">Level 3: Input prices quoted that are significant to the fair value of the financial assets or liabilities which are not observable or supported by an active market.</font></div> </td> </tr> </table> &#160;<font style="FONT-SIZE: 10pt">&#160;</font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">To the extent that the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for instruments categorized in Level 3. A financial instrument&#8217;s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The Company issued warrants to purchase an aggregate of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 82,500</font> common shares in a February 2013 public offering (the &#8220;February 2013 Public Offering Warrants&#8221;). On February 20, 2014, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 27,500</font> of the February 2013 Public Offering Warrants expired. On May 20, 2016, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 16,250</font> warrants were exercised. The remaining <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 38,750</font> warrants are classified within the Level 3 hierarchy.</font></div> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">In August 2014, as part of an underwritten public offering, the Company issued <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 494,315</font> warrants to purchase common stock (the &#8220;August 2014 Warrants&#8221;). The August 2014 Warrants are listed on the NASDAQ Capital Market under the symbol &#8220;CLRBW,&#8221; however, there are certain periods where trading volume is low; therefore, they are classified as Level 2 within the hierarchy.</font></div> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The following tables set forth the Company&#8217;s financial instruments carried at fair value using the lowest level of input applicable to each financial instrument as of March 31, 2017 and December 31, 2016:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="59%" colspan="11"> <div>March&#160;31,&#160;2017</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Level&#160;1</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Level&#160;2</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Level&#160;3</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Fair&#160;Value</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="39%"> <div>Liabilities:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>February 2013 Public Offering Warrants</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>49,600</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>49,600</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>August 2014 Warrants</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>160,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>160,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>160,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>49,600</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>209,600</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="59%" colspan="11"> <div>December&#160;31,&#160;2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Level&#160;1</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Level&#160;2</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Level&#160;3</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Fair&#160;Value</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="39%"> <div>Liabilities:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>February 2013 Public Offering Warrants</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>27,125</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>27,125</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>August 2014 Warrants</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>100,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>100,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>100,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>27,125</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>127,125</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">In order to estimate the value of the February 2013 Public Offering Warrants considered to be derivative instruments, the Company uses a modified option-pricing model together with assumptions that consider, among other variables, the fair value of the underlying stock, risk-free interest rates, volatility, the contractual term of the warrants, future financing requirements and dividend rates. The future financing estimates are based on the Company&#8217;s estimates of anticipated cash requirements over the term of the warrants as well as the frequency of required financings based on its assessment of its historical financing trends and anticipated future events. Due to the nature of these inputs and the valuation technique utilized, these warrants are classified within the Level 3 hierarchy.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The following table summarizes the modified option-pricing assumptions used:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Three&#160;Months</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Twelve&#160;Months</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Ended</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Ended</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>March&#160;31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>December&#160;31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>2017</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>Volatility</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>118</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>92.72-134</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>Risk-free interest rate</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>1.03</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>0.53-1.15</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>Expected life (years)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>0.89</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>1.14-1.89</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>Dividend</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>0</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>0</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> </table> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">During fiscal year 2016, the Company had warrants outstanding for part of the year that were considered financial instruments. Those warrants were either extinguished or amended such that they were no longer considered financial instruments as of December&#160;31, 2016, and were, therefore, not financial instruments during the quarter ended March&#160;31, 2017.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> The following table summarizes the modified option-pricing assumptions used for the period they were considered financial instruments:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 80%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="67%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Twelve&#160;Months</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="67%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Ended</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="67%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>December&#160;31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="67%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="67%"> <div>Volatility</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>89.73</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="67%"> <div>Risk-free interest rate</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1.65</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="67%"> <div>Expected life (years)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>4.50</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="67%"> <div>Dividend</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>0</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> </table> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The following table summarizes the changes in the fair market value of the Company&#8217;s warrants which are classified within the Level 3 fair value hierarchy.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Three&#160;Months</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Twelve&#160;Months</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Ended</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Ended</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>March&#160;31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>December&#160;31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>2017</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>Beginning balance &#150; Fair value</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>27,125</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>2,067,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>Reclassification to equity for warrants that are no longer derivative liabilities</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>(1,392,429)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>Loss (gain) on derivatives resulting from change in fair value or extinguishment</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>22,475</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>(647,446)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>Ending balance &#150; Fair value</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>49,600</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>27,125</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">To estimate the fair value of the August 2014 Warrants, the Company calculated the weighted average closing price for the trailing 10 day period with trades that ended on the balance sheet date.</font></div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><i><font style="FONT-SIZE: 10pt">Principles of Consolidation</font></i></b> <font style="FONT-SIZE: 10pt">&#151; The consolidated financial statements include the accounts of the Company and the accounts of its wholly-owned subsidiary. All significant intercompany accounts and transactions have been eliminated.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><i><font style="FONT-SIZE: 10pt">Restricted Cash</font></i></b> <font style="FONT-SIZE: 10pt">&#151; The Company accounts for cash that is restricted for other than current operations as restricted cash. Restricted cash at March 31, 2017 and December 31, 2016 consisted of a certificate of deposit of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">55,000</font></font> required under the Company&#8217;s lease agreement for its Madison, Wisconsin facility.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><i><font style="FONT-SIZE: 10pt">Goodwill</font></i></b> <font style="FONT-SIZE: 10pt">&#151; Goodwill is not amortized, but is required to be evaluated for impairment annually or whenever events or changes in circumstances suggest that the carrying value of an asset may not be recoverable. The Company evaluates goodwill for impairment annually in the fourth fiscal quarter and additionally on an interim basis if an event occurs or there is a change in circumstances, such as a decline in the Company&#8217;s stock price or a material adverse change in the business climate, which would more likely than not reduce the fair value of the reporting unit below its carrying amount. No such event or change in circumstances occurred; therefore, no changes in goodwill were made during the three months ended March&#160;31, 2017 and 2016.</font></div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">In January 2017, the FASB issued ASU No. 2017-04, Simplifying the Test for Goodwill. The standard streamlines the methodology for calculating whether goodwill is impaired based upon whether the carrying amount of goodwill exceeds the reporting unit&#8217;s fair value. ASU 2017-04 applies to public business entities and those other entities that have goodwill reported in their financial statements and have not elected the private company alternative for the subsequent measurement of goodwill and is effective for annual and interim reporting periods beginning after December&#160;15, 2019, with early adoption permitted. The Company does not expect that the adoption of this standard will have a material effect on its financial statements.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><i><font style="FONT-SIZE: 10pt">Stock-Based Compensation</font></i></b> <font style="FONT-SIZE: 10pt">&#151; The Company uses the Black-Scholes option-pricing model to calculate the grant-date fair value of stock option awards. The resulting compensation expense, net of expected forfeitures, for awards that are not performance-based is recognized on a straight-line basis over the service period of the award, which is generally three years for stock options. For stock options with performance-based vesting provisions, recognition of compensation expense, net of expected forfeitures, commences if and when the achievement of the performance criteria is deemed probable. The compensation expense, net of expected forfeitures, for performance-based stock options is recognized over the relevant performance period. Awards of stock that are not performance-based are valued at the fair market value on the date of the grant and are amortized over the service period of the award. Non-employee stock-based compensation is accounted for in accordance with the guidance of Financial Accounting Standards Board Accounting Standards Codification (&#8220;FASB ASC&#8221;) Topic 505, <i> Equity.&#160;</i> As such, the Company recognizes expense based on the estimated fair value of options granted to non-employees over their vesting period, which is generally the period during which services are rendered and deemed completed by such non-employees.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><i><font style="FONT-SIZE: 10pt">Impairment of Long</font></i></b><font style="FONT-SIZE: 10pt">-<b><i>Lived Assets</i></b> &#151; Long-lived assets other than goodwill consist primarily of fixed assets, which we periodically evaluate for potential impairment. Whenever events or circumstances change, an assessment is made as to whether there has been an impairment in the value of long-lived assets by determining whether projected undiscounted cash flows generated by the applicable asset exceed its net book value as of the assessment date. No such event or change in circumstances occurred; therefore, no such impairment occurred during the three months ended March&#160;31, 2017 and 2016.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><i><font style="FONT-SIZE: 10pt">Fair Value of Financial Instruments</font></i></b> <font style="FONT-SIZE: 10pt">&#151; The guidance under FASB ASC Topic 825, <i>Financial Instruments</i>, requires disclosure of the fair value of certain financial instruments. Financial instruments in the accompanying financial statements consist of cash equivalents, accounts payable and long-term obligations.&#160; The carrying amount of cash equivalents and accounts payable approximate their fair value due to their short-term nature.&#160; The carrying value of remaining long-term obligations, including the current portion, approximates fair value because the fixed interest rate approximates current market interest rates available on similar instruments.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><i><font style="FONT-SIZE: 10pt">Derivative Instruments</font></i></b> <font style="FONT-SIZE: 10pt">&#151; The Company generally does not use derivative instruments to hedge exposures to cash flow or market risks.&#160; However, certain warrants to purchase common stock that do not meet the requirements for classification as equity, in accordance with the Derivatives and Hedging Topic of the FASB ASC, are classified as liabilities.&#160; In such instances, net-cash settlement is assumed for financial reporting purposes, even when the terms of the underlying contracts do not provide for a net-cash settlement. These warrants are considered derivative instruments because the agreements contain a certain type of cash settlement feature, &#8220;down-round&#8221; provisions whereby the number of shares for which the warrants are exercisable and/or the exercise price of the warrants is subject to change in the event of certain issuances of stock at prices below the then-effective exercise price of the warrants. The number of shares issuable under such warrants was <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 533,065</font></font> at March&#160;31, 2017 and December 31, 2016. The primary underlying risk exposure pertaining to the warrants is the change in fair value of the underlying common stock.&#160; Such financial instruments are initially recorded at fair value with subsequent changes in fair value recorded as a component of gain or loss on derivatives on the consolidated statements of operations in each reporting period. If these instruments subsequently meet the requirements for equity classification, the Company reclassifies the fair value to equity. At March&#160;31, 2017 and December 31, 2016, these warrants represented the only outstanding derivative instruments issued or held by the Company.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><font style="FONT-SIZE: 10pt">Leases</font></b> <font style="FONT-SIZE: 10pt">&#151; In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) which supersedes FASB ASC Topic 840, Leases (Topic 840) and provides principles for the recognition, measurement, presentation and disclosure of leases for both lessees and lessors. The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight-line basis over the term of the lease, respectively. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than twelve months regardless of classification. Leases with a term of twelve months or less will be accounted for similar to existing guidance for operating leases. The standard is effective for annual and interim periods beginning after December 15, 2018, with early adoption permitted upon issuance. The Company is currently evaluating the method of adoption and the impact of adopting ASU 2016-02 on its results of operations, cash flows and financial position.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The following tables set forth the Company&#8217;s financial instruments carried at fair value using the lowest level of input applicable to each financial instrument as of March 31, 2017 and December 31, 2016:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="59%" colspan="11"> <div>March&#160;31,&#160;2017</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Level&#160;1</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Level&#160;2</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Level&#160;3</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Fair&#160;Value</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="39%"> <div>Liabilities:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>February 2013 Public Offering Warrants</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>49,600</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>49,600</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>August 2014 Warrants</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>160,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>160,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>160,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>49,600</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>209,600</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="59%" colspan="11"> <div>December&#160;31,&#160;2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Level&#160;1</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Level&#160;2</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Level&#160;3</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Fair&#160;Value</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="39%"> <div>Liabilities:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>February 2013 Public Offering Warrants</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>27,125</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>27,125</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>August 2014 Warrants</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>100,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>100,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="39%"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>100,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>27,125</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>127,125</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> The following table summarizes the modified option-pricing assumptions used: <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Three&#160;Months</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Twelve&#160;Months</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Ended</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Ended</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>March&#160;31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>December&#160;31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>2017</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>Volatility</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>118</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>92.72-134</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>Risk-free interest rate</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>1.03</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>0.53-1.15</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>Expected life (years)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>0.89</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>1.14-1.89</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>Dividend</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>0</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>0</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> The following table summarizes the modified option-pricing assumptions used for the period they were considered financial instruments: <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 80%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="67%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Twelve&#160;Months</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="67%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>Ended</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="67%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>December&#160;31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="67%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="67%"> <div>Volatility</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>89.73</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="67%"> <div>Risk-free interest rate</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1.65</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="67%"> <div>Expected life (years)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>4.50</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="67%"> <div>Dividend</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>0</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The following table summarizes the changes in the fair market value of the Company&#8217;s warrants which are classified within the Level 3 fair value hierarchy.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Three&#160;Months</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Twelve&#160;Months</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Ended</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Ended</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>March&#160;31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>December&#160;31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>2017</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>Beginning balance &#150; Fair value</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>27,125</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>2,067,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>Reclassification to equity for warrants that are no longer derivative liabilities</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>(1,392,429)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>Loss (gain) on derivatives resulting from change in fair value or extinguishment</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>22,475</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>(647,446)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>Ending balance &#150; Fair value</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>49,600</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>27,125</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 27125 2067000 0 1392429 22475 -647446 49600 1.18 0.0103 P10M20D 0 0 0.9272 1.34 0.0053 0.0115 P1Y1M20D P1Y10M20D 0.0165 P4Y6M 0 16250 38750 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><font style="FONT-SIZE: 10pt">3. STOCKHOLDERS&#8217; EQUITY</font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><i><font style="FONT-SIZE: 10pt">November 2016 Underwritten Offering</font></i></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">On November 23, 2016, the Company entered into an Underwriting Agreement with Ladenburg Thalmann &amp; Co. Inc., as representative of the several underwriters named therein, in connection with the Company&#8217;s Registration Statement on Form S-1. Pursuant to the Underwriting Agreement, the Company agreed to sell to the Underwriter <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 800,000</font> shares of common stock, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">68</font> shares of Series A preferred stock convertible into <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 4,533,356</font> shares of common stock and Series C warrants to purchase <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 5,333,356</font> shares of common stock, plus up to an additional <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 800,000</font> shares of common stock and Series C warrants to purchase up to an additional <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 800,000</font> shares of common stock in the event of the exercise by the Underwriter of its over-allotment option. The public offering price of a share of common stock together with a Series C warrant to purchase one share of common stock was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1.50</font>. The public offering price to purchase one share of Series A preferred stock, each of which is convertible into <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 66,667</font> shares of common stock, together with a Series C warrant to purchase <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 66,667</font> shares of common stock was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">100,000</font>. The preferred stock was non-voting, had no dividend rights (except to the extent dividends were also paid on common stock), liquidation preference, or other preferences over common stock. The Series C warrants have an exercise price of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1.50</font> per share, and are exercisable for five years from the date of issuance. The net proceeds were allocated to each security based upon the pro-rata values of the underlying common stock and a Black-Scholes valuation of the warrants.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The sale of securities pursuant to the Underwriting Agreement, including the entire over-allotment option, closed on November 29, 2016 (the &#8220;November 2016 Underwritten Offering&#8221;). Gross proceeds were $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">9.2</font> million with net proceeds to the Company of approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">8.3</font> million.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">As of December 31, 2016, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">17</font> shares of Series A preferred stock were outstanding. During the three months ended March&#160;31, 2017, all <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">17</font> shares were converted into <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 1,133,339</font> shares of common stock.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">During the three months ended March 31, 2017, Series C warrants representing <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 1,956,506</font> shares of common stock were exercised by the holders, for proceeds of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2,934,759</font>.</font></div> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><i><font style="FONT-SIZE: 10pt">April 2016 Underwritten Offering</font></i></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">On April 15, 2016, the Company entered into an Underwriting Agreement with Ladenburg Thalmann &amp; Co., Inc. in connection with the Company&#8217;s Registration Statement on Form S-1. Pursuant to the Underwriting Agreement, the Company agreed to sell to the Underwriter <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 1,378,364</font> shares of common stock, Series B prefunded warrants to purchase <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 1,908,021</font> shares of common stock and Series A warrants to purchase <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 3,286,385</font> shares of common stock, plus up to an additional <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 492,957</font> shares of common stock and Series A warrants to purchase up to an additional <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 492,957</font> shares of common stock in the event of the exercise by the Underwriter of its over-allotment option. The public offering price of a share of common stock together with a Series A warrant to purchase one share of common stock was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2.13</font>. The public offering price of a Series B pre-funded warrant to purchase one share of common stock together with a Series A warrant to purchase one share of common stock was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2.12</font>. The Series B pre-funded warrants had an exercise price of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">0.01</font> per share, were immediately exercisable and do not expire. The Series A warrants have an exercise price of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3.04</font> per share, are exercisable for five years from the date of issuance, and are callable by the Company under certain circumstances.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">On April 20, 2016, the Company closed on the underwritten public offering (the &#8220;April 2016 Underwritten Offering&#8221;) of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 1,871,321</font> shares of its common stock and Series B pre-funded warrants to purchase <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 1,908,021</font> shares of common stock, plus the issuance of Series A warrants to purchase <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 3,779,342</font> shares of common stock, reflecting the exercise in full of the Underwriter&#8217;s over-allotment option. The gross proceeds of the offering amounted to approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">8.0</font> million with net proceeds to the Company of approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">7.2</font> million.</font></div> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><i><font style="FONT-SIZE: 10pt">Warrant Restructuring</font></i></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">On April 13, 2016, the Company entered into an exchange and amendment agreement (the &#8220;Warrant Restructuring Agreement&#8221;). Pursuant to the Warrant Restructuring Agreement, the Company agreed with the holders of 2015 Series A warrants that upon the consummation of the 2016 Underwritten Offering, the exercise price of the 2015 Series A warrants would be reduced to the public offering price per share of the shares of common stock sold in this offering and that the warrants would be amended such that the exercise price would no longer be subject to adjustment in connection with future equity offerings we may undertake. In consideration of this amendment, the Company agreed to issue to each of those holders a new warrant to purchase an additional number of shares of common stock equal to twice the number of shares of common stock underlying the 2015 Series A Warrants held by them (the &#8220;Incremental Series A Warrants&#8221;). As a result, the 2015 Series A warrants and the Incremental Series A Warrants have an exercise price equal to $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2.13</font> (the public offering price of the shares of common stock sold in the 2016 Underwritten Offering).</font></div> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><i><font style="FONT-SIZE: 10pt">2016 Reverse Stock Split and Recapitalization</font></i></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>At a special meeting held on February 8, 2016, the Company&#8217;s stockholders approved an amendment to the Company&#8217;s certificate of incorporation to effect a reverse split of the Company&#8217;s common stock at a ratio between 1:5 to 1:10 in order to ensure that adequate authorized but unissued shares would be available for anticipated future financings, and to satisfy requirements for the continued listing of the Company&#8217;s common stock on the NASDAQ Capital Market. In addition, the proposal approved by the stockholders provided that if the reverse split was effected, the number of shares of common stock that the Company is authorized to issue remained unchanged at <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 40,000,000</font>. The Company&#8217;s stockholders further authorized the board of directors to determine the ratio at which the reverse split would be effected by filing an appropriate amendment to the Company&#8217;s certificate of incorporation. The board of directors authorized the ratio of the reverse split on February 24, 2016, and effective at the close of business on March 4, 2016, the Company&#8217;s certificate of incorporation was amended to effect a <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>1-for-10 reverse split <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>of the Company&#8217;s common stock (the &#8220;2016 Reverse Split&#8221;). All share and per share numbers included in these consolidated financial statements give effect to the 2016 Reverse Split.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></font></div> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><i><font style="FONT-SIZE: 10pt">Common Stock Warrants</font></i></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The following table summarizes information with regard to outstanding warrants to purchase common stock as of March&#160;31, 2017.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="52%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Number&#160;of&#160;Shares</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="15%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="52%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Issuable&#160;Upon</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="15%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="52%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Exercise&#160;of</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="15%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="52%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Outstanding</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Exercise</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="15%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="52%"> <div>Offering</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Warrants</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Price</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="15%"> <div>Expiration&#160;Date</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="52%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="15%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>November 2016 Public Offering Series C</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>4,176,850</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>1.50</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%"> <div>November 29, 2021</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>April 2016 Underwritten Registered Series A</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>3,626,942</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>3.04</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%"> <div>April 20, 2021</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>October 2015 Incremental Series A</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>300,006</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>2.13</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%"> <div>October 20, 2021</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>October 2015 Private Placement Series A</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>86,365</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>2.13</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%"> <div>April 1, 2021</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>October 2015 Offering &#150; Placement Agent</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>3,750</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>28.30</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%"> <div>October 1, 2020</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>August 2014 Public Offering <sup style="font-style:normal"> (1)</sup></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>504,019</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>46.80</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%"> <div>August 20, 2019</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>February 2013 Public Offering <sup style="font-style:normal"> (1)</sup></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>38,750</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>1.50</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div><sup style="font-style:normal">(2)</sup></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%"> <div>February 20, 2018</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>February 2013 Public Offering &#150; Placement Agents</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>3,854</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>125.00</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%"> <div>February 4, 2018</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>November 2012 Private Placement</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>5,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>250.00</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%"> <div>November 2, 2017</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>June 2012 Public Offering</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>14,910</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>250.00</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%"> <div>June 13, 2017</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>8,760,446</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%"> <div>&#160;</div> </td> </tr> </table> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; LINE-HEIGHT: 115%; WIDTH: 100%; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 0.25in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="24"></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 0.25in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="24"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt"> <font style="FONT-SIZE: 10pt">(1)</font></div> </td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt"> <font style="FONT-SIZE: 10pt">These warrants have a certain type of cash settlement feature or their exercise prices for which the warrant may be exercised are subject to adjustment for &#8220;down-rounds&#8221; and the warrants have been accounted for as derivative instruments as described in Note 3, with the exception of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 9,704</font> warrants issued in August 2014.</font></div> </td> </tr> </table> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt"> <font style="DISPLAY: none; FONT-SIZE: 10pt">&#160;</font></div> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; LINE-HEIGHT: 115%; WIDTH: 100%; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 0.25in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="24"></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 0.25in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="24"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt"> <font style="FONT-SIZE: 10pt">(2)</font></div> </td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt"> <font style="FONT-SIZE: 10pt">Due to the issuance of common stock at $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1.50</font> per share as part of the November 2016 Underwritten Offering, the remaining outstanding warrants issued as part of the February 2013 Public Offering were adjusted to reflect the revised exercise price of $1.50 each.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></font></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><i><font style="FONT-SIZE: 10pt">Reserved Shares</font></i></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The following shares were reserved for future issuance upon exercise of stock options, preferred stock conversions and warrants:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="MARGIN: 0px:auto; WIDTH: 80%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>March&#160;31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>December&#160;31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2017</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>Warrants</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8,760,446</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>10,716,952</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>Preferred stock</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1,133,339</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>Stock options</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>508,733</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>471,433</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>Total number of shares reserved for future issuance</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>9,269,179</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>12,321,724</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The following table summarizes information with regard to outstanding warrants to purchase common stock as of March&#160;31, 2017.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="52%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Number&#160;of&#160;Shares</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="15%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="52%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Issuable&#160;Upon</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="15%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="52%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Exercise&#160;of</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="15%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="52%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Outstanding</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Exercise</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="15%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="52%"> <div>Offering</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Warrants</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Price</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="15%"> <div>Expiration&#160;Date</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="52%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="15%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>November 2016 Public Offering Series C</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>4,176,850</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>1.50</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%"> <div>November 29, 2021</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>April 2016 Underwritten Registered Series A</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>3,626,942</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>3.04</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%"> <div>April 20, 2021</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>October 2015 Incremental Series A</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>300,006</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>2.13</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%"> <div>October 20, 2021</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>October 2015 Private Placement Series A</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>86,365</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>2.13</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%"> <div>April 1, 2021</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>October 2015 Offering &#150; Placement Agent</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>3,750</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>28.30</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%"> <div>October 1, 2020</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>August 2014 Public Offering <sup style="font-style:normal"> (1)</sup></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>504,019</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>46.80</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%"> <div>August 20, 2019</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>February 2013 Public Offering <sup style="font-style:normal"> (1)</sup></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>38,750</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>1.50</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div><sup style="font-style:normal">(2)</sup></div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%"> <div>February 20, 2018</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>February 2013 Public Offering &#150; Placement Agents</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>3,854</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>125.00</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%"> <div>February 4, 2018</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>November 2012 Private Placement</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>5,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>250.00</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%"> <div>November 2, 2017</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>June 2012 Public Offering</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>14,910</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>250.00</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%"> <div>June 13, 2017</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="52%"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>8,760,446</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%"> <div>&#160;</div> </td> </tr> </table> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; LINE-HEIGHT: 115%; WIDTH: 100%; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 0.25in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="24"></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 0.25in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="24"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt"> <font style="FONT-SIZE: 10pt">(1)</font></div> </td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt"> <font style="FONT-SIZE: 10pt">These warrants have a certain type of cash settlement feature or their exercise prices for which the warrant may be exercised are subject to adjustment for &#8220;down-rounds&#8221; and the warrants have been accounted for as derivative instruments as described in Note 3, with the exception of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 9,704</font> warrants issued in August 2014.</font></div> </td> </tr> </table> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt"> <font style="DISPLAY: none; FONT-SIZE: 10pt">&#160;</font></div> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; LINE-HEIGHT: 115%; WIDTH: 100%; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 0.25in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="24"></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 0.25in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="24"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt"> <font style="FONT-SIZE: 10pt">(2)</font></div> </td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt"> <font style="FONT-SIZE: 10pt">Due to the issuance of common stock at $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">1.50</font> per share as part of the November 2016 Underwritten Offering, the remaining outstanding warrants issued as part of the February 2013 Public Offering were adjusted to reflect the revised exercise price of $1.50 each.</font></div> </td> </tr> </table> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The following shares were reserved for future issuance upon exercise of stock options, preferred stock conversions and warrants:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="MARGIN: 0px:auto; WIDTH: 80%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>March&#160;31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>December&#160;31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2017</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="11%" colspan="2"> <div>2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>Warrants</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8,760,446</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>10,716,952</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>Preferred stock</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1,133,339</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>Stock options</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>508,733</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>471,433</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="55%"> <div>Total number of shares reserved for future issuance</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>9,269,179</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>12,321,724</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 1133339 1956506 2934759 9704 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><font style="FONT-SIZE: 10pt">5. STOCK-BASED COMPENSATION</font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><font style="FONT-SIZE: 10pt">Accounting for Stock-Based Compensation</font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The following table summarizes amounts charged to expense for stock-based compensation related to employee and director stock option grants and recorded in connection with stock options granted to non-employee consultants:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="29%" colspan="5"> <div>Three&#160;Months&#160;Ended</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="29%" colspan="5"> <div>March&#160;31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>2017</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>Employee and director stock option grants:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>Research and development</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>16,648</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>11,035</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>General and administrative</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>149,026</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>92,249</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>165,674</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>103,284</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>Non-employee consultant stock option grants:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>Research and development</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>(366)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>(366)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 20px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>Total stock-based compensation</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>165,674</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>102,918</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><font style="FONT-SIZE: 10pt">Assumptions Used In Determining Fair Value</font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <i><font style="FONT-SIZE: 10pt">Valuation and amortization method</font></i><font style="FONT-SIZE: 10pt">. The fair value of each stock award is estimated on the grant date using the Black-Scholes option-pricing model.&#160; The estimated fair value of employee stock options is amortized to expense using the straight-line method over the vesting period. The estimated fair value of the non-employee options is amortized to expense over the period during which a non-employee is required to provide services for the award (usually the vesting period).</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <i><font style="FONT-SIZE: 10pt">Volatility.</font></i> <font style="FONT-SIZE: 10pt">The Company estimates volatility based on an average of (1) the Company&#8217;s historical volatility since its common stock has been publicly traded and (2) review of volatility estimates of publicly held drug development companies with similar market capitalizations.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <i><font style="FONT-SIZE: 10pt">Risk-free interest rate</font></i><font style="FONT-SIZE: 10pt">. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant commensurate with the expected term assumption.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <i><font style="FONT-SIZE: 10pt">Expected term</font></i><font style="FONT-SIZE: 10pt">. The expected term of stock options granted is based on an estimate of when options will be exercised in the future. The Company applied the simplified method of estimating the expected term of the options, as described in the SEC&#8217;s Staff Accounting Bulletins 107 and 110, as the historical experience is not indicative of the expected behavior in the future. The expected term, calculated under the simplified method, is applied to groups of stock options that have similar contractual terms. Using this method, the expected term is determined using the average of the vesting period and the contractual life of the stock options granted. The Company applied the simplified method to non-employees who have a truncation of term based on termination of service and utilizes the contractual life of the stock options granted for those non-employee grants which do not have a truncation of service.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0in 0in 0pt"> <i><font style="FONT-SIZE: 10pt">Forfeitures.</font></i> <font style="FONT-SIZE: 10pt">The Company records stock-based compensation expense only for those awards that are expected to vest. A forfeiture rate is estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from initial estimates. An annual forfeiture rate of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 2</font>% was applied to all unvested options for employees and directors, respectively, for the three months ended March 31, 2017 and for the year ended December 31, 2016.&#160; Ultimately, the actual expense recognized over the vesting period will be for only those shares that vest.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <font style="FONT-SIZE: 10pt">Exercise prices for all grants made during the three months ended March 31, 2017 were equal to the market value of the Company&#8217;s common stock on the date of grant. There were no stock option grants during the three months ended March&#160;31, 2016.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><font style="FONT-SIZE: 10pt">&#160;</font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><font style="FONT-SIZE: 10pt">Stock Option Activity</font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>A summary of stock option activity is as follows:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Weighted</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Number&#160;of</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Average</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Shares&#160;Issuable</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Remaining</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Upon&#160;Exercise</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Weighted</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Contracted</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Aggregate</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>of&#160;Outstanding</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Average</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Term&#160;in</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Intrinsic</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Options</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Exercise&#160;Price</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Years</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Value</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Outstanding at December 31, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>471,433</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>7.59</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Granted</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>37,300</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>2.18</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Expired</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Forfeited</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Outstanding at March 31, 2017</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>508,733</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>7.19</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Vested, March 31, 2017</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>104,106</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>19.84</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>8.70</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>54,579</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Unvested, March 31, 2017</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="13%"> <div>404,627</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>3.94</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>9.17</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="13%"> <div>167,134</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Exercisable at March 31, 2017</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="13%"> <div>104,106</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>19.84</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>8.70</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="13%"> <div>54,579</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The aggregate intrinsic value of options outstanding is calculated based on the positive difference between the estimated per-share fair value of common stock at the end of the respective period and the exercise price of the underlying options.&#160; There have been no option exercises to date. Shares of common stock issued upon the exercise of options are from authorized but unissued shares.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">As of March 31, 2017, there was approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">950,882</font> of total unrecognized compensation cost related to unvested stock-based compensation arrangements.&#160; Of this total amount, the Company expects to recognize approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">372,648</font>, $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">391,798</font>, $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">186,079</font>, and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">357</font> during 2017, 2018, 2019 and 2020, respectively. The Company&#8217;s expense estimates are based upon the expectation that all unvested options will vest in the future, less the forfeiture rate discussed above. The weighted-average grant-date fair value of vested and unvested options outstanding at March 31, 2017 was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">14.95</font> and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3.20</font>, respectively.</font></div> </div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The following table summarizes amounts charged to expense for stock-based compensation related to employee and director stock option grants and recorded in connection with stock options granted to non-employee consultants:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="29%" colspan="5"> <div>Three&#160;Months&#160;Ended</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="29%" colspan="5"> <div>March&#160;31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>2017</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="14%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>Employee and director stock option grants:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>Research and development</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>16,648</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>11,035</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>General and administrative</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>149,026</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>92,249</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>165,674</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>103,284</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>Non-employee consultant stock option grants:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>Research and development</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>(366)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>(366)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 20px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="69%"> <div>Total stock-based compensation</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>165,674</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>102,918</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">A summary of stock option activity is as follows:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Weighted</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Number&#160;of</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Average</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Shares&#160;Issuable</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Remaining</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Upon&#160;Exercise</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Weighted</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Contracted</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Aggregate</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>of&#160;Outstanding</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Average</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Term&#160;in</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Intrinsic</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Options</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Exercise&#160;Price</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Years</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="14%" colspan="2"> <div>Value</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Outstanding at December 31, 2016</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>471,433</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>7.59</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Granted</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>37,300</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>2.18</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Expired</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 13px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Forfeited</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#151;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Outstanding at March 31, 2017</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="13%"> <div>508,733</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>7.19</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Vested, March 31, 2017</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>104,106</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>19.84</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>8.70</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>54,579</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Unvested, March 31, 2017</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="13%"> <div>404,627</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>3.94</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>9.17</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="13%"> <div>167,134</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Exercisable at March 31, 2017</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="13%"> <div>104,106</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>19.84</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="13%"> <div>8.70</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="13%"> <div>54,579</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 165674 103284 0 -366 372648 391798 357 3.20 186079 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><font style="FONT-SIZE: 10pt">6. &#160;INCOME TAXES</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The Company accounts for income taxes in accordance with the liability method of accounting. Deferred tax assets or liabilities are computed based on the difference between the financial statement and income tax basis of assets and liabilities, and net operating loss carryforwards, (NOLs) using the enacted tax rates. Deferred income tax expense or benefit is based on changes in the asset or liability from period to period. The Company did not record a provision or benefit for federal, state or foreign income taxes for the three months ended March 31, 2017 or 2016 because the Company has experienced losses on a tax basis since inception. Because of the limited operating history, continuing losses and uncertainty associated with the utilization of the NOLs in the future, management has provided a full allowance against the value of its gross deferred tax assets.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The Company also accounts for the uncertainty in income taxes related to the recognition and measurement of a tax position taken or expected to be taken in an income tax return. The Company follows the applicable accounting guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition related to the uncertainty in income tax positions. No uncertain tax positions have been identified.</font></div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The following potentially dilutive securities have been excluded from the computation of diluted net income (loss) per share since their inclusion would be antidilutive:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 70%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="21%" colspan="5"> <div>Three&#160;Months&#160;Ended&#160;March&#160;31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>2017</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>Warrants</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>8,760,446</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>782,782</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>Stock options</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="9%"> <div>508,733</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="9%"> <div>68,582</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><font style="FONT-SIZE: 10pt">7. NET INCOME (LOSS) PER SHARE</font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. Diluted net income per share for the three months ended March 31, 2016 is computed by dividing net income by the sum of the weighted average number of shares of common stock and the dilutive potential common stock equivalents then outstanding.&#160; Potential common stock equivalents consist of stock options and warrants. Since there is a net loss attributable to common stockholders for the three months ended March&#160;31, 2017, the inclusion of common stock equivalents in the computation for that period would be antidilutive.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The following potentially dilutive securities have been excluded from the computation of diluted net income (loss) per share since their inclusion would be antidilutive:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="MARGIN: 0in; WIDTH: 70%; BORDER-COLLAPSE: collapse; OVERFLOW: visible" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700" width="21%" colspan="5"> <div>Three&#160;Months&#160;Ended&#160;March&#160;31,</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>2017</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 700" width="10%" colspan="2"> <div>2016</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: times new roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>Warrants</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>8,760,446</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="9%"> <div>782,782</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #cceeff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="47%"> <div>Stock options</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="9%"> <div>508,733</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 4px; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="9%"> <div>68,582</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: times new roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><font style="FONT-SIZE: 10pt">8.&#160; COMMITMENTS AND CONTINGENCIES</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The Company is involved in legal matters and disputes in the ordinary course of business. We do not anticipate that the outcome of such matters and disputes will materially affect the Company&#8217;s financial statements.</font></div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> At a special meeting held on February 8, 2016, the Companys stockholders approved an amendment to the Companys certificate of incorporation to effect a reverse split of the Companys common stock at a ratio between 1:5 to 1:10 in order to ensure that adequate authorized but unissued shares would be available for anticipated future financings, and to satisfy requirements for the continued listing of the Companys common stock on the NASDAQ Capital Market. In addition, the proposal approved by the stockholders provided that if the reverse split was effected, the number of shares of common stock that the Company is authorized to issue remained unchanged at 40,000,000. The Companys stockholders further authorized the board of directors to determine the ratio at which the reverse split would be effected by filing an appropriate amendment to the Companys certificate of incorporation. The board of directors authorized the ratio of the reverse split on February 24, 2016, and effective at the close of business on March 4, 2016, the Companys certificate of incorporation was amended to effect a 1-for-10 reverse split of the Companys common stock (the 2016 Reverse Split). All share and per share numbers included in these consolidated financial statements give effect to the 2016 Reverse Split. 1-for-10 reverse split <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><font style="FONT-SIZE: 10pt">4. NOTES PAYABLE</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">During the quarter ended March 31, 2017, the two loans with initial principal amounts totaling $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">450,000</font> from the Wisconsin Economic Development Corporation, dated September 15, 2010, were paid in full.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 0.8973 0.02 0.02 0.02 0.02 These warrants have a certain type of cash settlement feature or their exercise prices for which the warrant may be exercised are subject to adjustment for “down-rounds” and the warrants have been accounted for as derivative instruments as described in Note 3, with the exception of 9,704 warrants issued in August 2014. Due to the issuance of common stock at $1.50 per share as part of the November 2016 Underwritten Offering, the remaining outstanding warrants issued as part of the February 2013 Public Offering were adjusted to reflect the revised exercise price of $1.50 each. EX-101.SCH 6 clrb-20170331.xsd XBRL TAXONOMY EXTENSION SCHEMA 101 - Document - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink 102 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS link:presentationLink link:definitionLink link:calculationLink 103 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS [Parenthetical] link:presentationLink link:definitionLink link:calculationLink 104 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:definitionLink link:calculationLink 105 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:definitionLink link:calculationLink 106 - Disclosure - NATURE OF BUSINESS, ORGANIZATION AND GOING CONCERN link:presentationLink link:definitionLink link:calculationLink 107 - Disclosure - FAIR VALUE link:presentationLink link:definitionLink link:calculationLink 108 - Disclosure - STOCKHOLDERS' EQUITY link:presentationLink link:definitionLink link:calculationLink 109 - Disclosure - NOTES PAYABLE link:presentationLink link:definitionLink link:calculationLink 110 - Disclosure - STOCK-BASED COMPENSATION link:presentationLink link:definitionLink link:calculationLink 111 - Disclosure - INCOME TAXES link:presentationLink link:definitionLink link:calculationLink 112 - Disclosure - NET INCOME (LOSS) PER SHARE link:presentationLink link:definitionLink link:calculationLink 113 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:definitionLink link:calculationLink 114 - Disclosure - NATURE OF BUSINESS, ORGANIZATION AND GOING CONCERN (Policies) link:presentationLink link:definitionLink link:calculationLink 115 - Disclosure - FAIR VALUE (Tables) link:presentationLink link:definitionLink link:calculationLink 116 - Disclosure - STOCKHOLDERS' EQUITY (Tables) link:presentationLink link:definitionLink link:calculationLink 117 - Disclosure - STOCK-BASED COMPENSATION (Tables) link:presentationLink link:definitionLink link:calculationLink 118 - Disclosure - NET INCOME (LOSS) PER SHARE (Tables) link:presentationLink link:definitionLink link:calculationLink 119 - Disclosure - NATURE OF BUSINESS, ORGANIZATION AND GOING CONCERN (Details Textual) link:presentationLink link:definitionLink link:calculationLink 120 - Disclosure - FAIR VALUE (Details) link:presentationLink link:definitionLink link:calculationLink 121 - Disclosure - FAIR VALUE (Details 1) link:presentationLink link:definitionLink link:calculationLink 122 - Disclosure - FAIR VALUE (Details 2) link:presentationLink link:definitionLink link:calculationLink 123 - Disclosure - FAIR VALUE (Details 3) link:presentationLink link:definitionLink link:calculationLink 124 - Disclosure - FAIR VALUE (Details Textual) link:presentationLink link:definitionLink link:calculationLink 125 - Disclosure - STOCKHOLDERS' EQUITY (Details) link:presentationLink link:definitionLink link:calculationLink 126 - Disclosure - STOCKHOLDERS' EQUITY (Details 1) link:presentationLink link:definitionLink link:calculationLink 127 - Disclosure - STOCKHOLDERS' EQUITY (Details Textual) link:presentationLink link:definitionLink link:calculationLink 128 - Disclosure - STOCK-BASED COMPENSATION (Details) link:presentationLink link:definitionLink link:calculationLink 129 - Disclosure - STOCK-BASED COMPENSATION (Details 1) link:presentationLink link:definitionLink link:calculationLink 130 - Disclosure - STOCK-BASED COMPENSATION (Details Textual) link:presentationLink link:definitionLink link:calculationLink 131 - Disclosure - NET INCOME (LOSS) PER SHARE (Details) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 7 clrb-20170331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 8 clrb-20170331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 9 clrb-20170331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 10 clrb-20170331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.7.0.1
Document And Entity Information - shares
 3 Months Ended
Mar. 31, 2017
May 08, 2017
Document Information [Line Items]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Mar. 31, 2017  
Document Fiscal Year Focus 2017  
Document Fiscal Period Focus Q1  
Entity Registrant Name Cellectar Biosciences, Inc.  
Entity Central Index Key 0001279704  
Current Fiscal Year End Date --12-31  
Entity Filer Category Smaller Reporting Company  
Trading Symbol CLRB  
Entity Common Stock, Shares Outstanding   13,462,170
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Mar. 31, 2017
Dec. 31, 2016
CURRENT ASSETS:    
Cash and cash equivalents $ 11,238,394 $ 11,444,619
Restricted cash 55,000 55,000
Prepaid expenses and other current assets 893,185 693,569
Total current assets 12,186,579 12,193,188
FIXED ASSETS, NET 1,423,448 1,444,058
GOODWILL 1,675,462 1,675,462
OTHER ASSETS 11,872 11,872
TOTAL ASSETS 15,297,361 15,324,580
CURRENT LIABILITIES:    
Current maturities of notes payable 0 86,591
Accounts payable and accrued liabilities 1,186,092 1,416,433
Derivative liability 209,600 127,125
Capital lease obligations, current portion 2,801 2,727
Total current liabilities 1,398,493 1,632,876
LONG-TERM LIABILITIES:    
Deferred rent 145,367 146,583
Capital lease obligations, current portion 4,520 5,249
Total long-term liabilities 149,887 151,832
TOTAL LIABILITIES 1,548,380 1,784,708
COMMITMENTS AND CONTINGENCIES (Note 8)
STOCKHOLDERS’ EQUITY:    
Preferred stock, $0.00001 par value; 7,000 shares authorized; none and 17 Series A issued and outstanding as of March 31, 2017 and December 31, 2016, respectively 0 875,572
Common stock, $0.00001 par value; 40,000,000 shares authorized; 13,458,170 and 10,368,325 shares issued and outstanding at March 31, 2017 and December 31, 2016, respectively 135 104
Additional paid-in capital 87,427,196 83,451,222
Accumulated deficit (73,678,350) (70,787,026)
Total stockholders’ equity 13,748,981 13,539,872
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 15,297,361 $ 15,324,580
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONDENSED CONSOLIDATED BALANCE SHEETS [Parenthetical] - $ / shares
Mar. 31, 2017
Dec. 31, 2016
Preferred stock, par value (in dollars per share) $ 0.00001 $ 0.00001
Preferred stock, shares authorized 7,000 7,000
Common stock, par value (in dollars per share) $ 0.00001 $ 0.00001
Common stock, shares authorized 40,000,000 40,000,000
Common stock, shares issued 13,458,170 10,368,325
Common stock, shares outstanding 13,458,170 10,368,325
Series A Preferred Stock [Member]    
Preferred stock, issued 0 17
Preferred stock, outstanding 0 17
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
 3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
COSTS AND EXPENSES:    
Research and development $ 1,856,880 $ 1,039,454
General and administrative 955,356 961,254
Total costs and expenses 2,812,236 2,000,708
LOSS FROM OPERATIONS (2,812,236) (2,000,708)
OTHER INCOME (EXPENSE):    
Gain (loss) on revaluation of derivative warrants (82,475) 2,824,722
Interest income, net 3,387 549
Total other income (expense), net (79,088) 2,825,271
NET INCOME (LOSS) $ (2,891,324) $ 824,563
BASIC NET INCOME (LOSS) PER COMMON SHARE $ (0.24) $ 0.96
SHARES USED IN COMPUTING BASIC NET INCOME (LOSS) PER COMMON SHARE 12,010,284 858,107
DILUTED NET INCOME (LOSS) PER COMMON SHARE $ (0.24) $ 0.91
SHARES USED IN COMPUTING DILUTED NET INCOME (LOSS) PER COMMON SHARE 12,010,284 906,381
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net income (loss) $ (2,891,324) $ 824,563
Adjustments to reconcile net income (loss) to cash used in operating activities:    
Depreciation and amortization 86,911 90,773
Stock-based compensation expense 165,674 102,918
(Gain) loss on revaluation of derivative warrants 82,475 (2,824,722)
Changes in:    
Accounts payable and accrued liabilities (230,341) (67,256)
Prepaid expenses and other current assets (199,616) 55,793
Other assets and liabilities (1,216) (325)
Cash used in operating activities (2,987,437) (1,818,256)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchases of fixed assets (66,301) 0
Cash used in investing activities (66,301) 0
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from exercise of warrants 2,934,759 0
Payments on notes payable (86,591) (60,528)
Payments on capital lease obligations (655) (588)
Cash paid for issuance costs 0 (69,450)
Reverse stock split fractional shares 0 (594)
Cash provided by (used in) financing activities 2,847,513 (131,160)
NET DECREASE IN CASH AND EQUIVALENTS (206,225) (1,949,416)
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD 11,444,619 3,857,791
CASH AND CASH EQUIVALENTS AT END OF PERIOD 11,238,394 1,908,375
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION    
Cash paid for interest expense $ 364 $ 1,467
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.7.0.1
NATURE OF BUSINESS, ORGANIZATION AND GOING CONCERN
 3 Months Ended
Mar. 31, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Nature Of Business Organization and Going Concern Disclosure [Text Block]
1. NATURE OF BUSINESS, ORGANIZATION AND GOING CONCERN
 
Cellectar Biosciences, Inc. (the “Company”) is a biopharmaceutical company developing compounds for the treatment and imaging of cancer. The Company’s headquarters are located in Madison, Wisconsin.
 
The Company is subject to a number of risks similar to those of other small pharmaceutical companies. Principal among these risks are dependence on key individuals, competition from substitute products and larger companies, the successful development and marketing of its products in a highly regulated environment and the need to obtain additional financing necessary to fund future operations.
 
The accompanying financial statements have been prepared on a basis that assumes that the Company will continue as a going concern and that contemplates the continuity of operations, realization of assets and the satisfaction of liabilities and commitments in the normal course of business. The Company has devoted substantially all of its efforts toward research and development and has, during the three months ended March 31, 2017, generated an operating loss of approximately $2,812,000. The Company expects that it will continue to generate operating losses for the foreseeable future.
 
The Company believes that its cash balance at March 31, 2017 is adequate to fund operations at budgeted levels into second quarter 2018. The Company’s ability to execute its operating plan beyond second quarter 2018 depends on its ability to obtain additional funding via the sale of equity and/or debt securities, a strategic transaction or otherwise. The Company plans to continue to actively pursue financing alternatives, but there can be no assurance that it will obtain the necessary funding, raising substantial doubt about the Company’s ability to continue as a going concern within one year of the date these financial statements are issued. The accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty.
 
The accompanying condensed consolidated balance sheet as of December 31, 2016 has been derived from audited financial statements. The accompanying unaudited condensed consolidated balance sheet as of March 31, 2017, the condensed consolidated statements of operations for the three months ended March 31, 2017 and 2016, the condensed consolidated statements of cash flows for the three months ended March 31, 2017 and 2016 and the related interim information contained within the notes to the condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and with the instructions, rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial information. Accordingly, they do not include all of the information and the notes required by U.S. GAAP for complete financial statements. In the opinion of management, the unaudited interim condensed consolidated financial statements reflect all adjustments which are of a nature necessary for the fair presentation of the Company’s consolidated financial position at March 31, 2017 and consolidated results of its operations for the three months ended March 31, 2017 and 2016, and its cash flows for the three months ended March 31, 2017 and 2016. The results for the three months ended March 31, 2017 are not necessarily indicative of future results.
 
These unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and related notes thereto included in the Company’s Form 10-K for the fiscal year ended December 31, 2016, which was filed with the SEC on March 15, 2017.
 
Principles of Consolidation — The consolidated financial statements include the accounts of the Company and the accounts of its wholly-owned subsidiary. All significant intercompany accounts and transactions have been eliminated.
 
Restricted Cash — The Company accounts for cash that is restricted for other than current operations as restricted cash. Restricted cash at March 31, 2017 and December 31, 2016 consisted of a certificate of deposit of $55,000 required under the Company’s lease agreement for its Madison, Wisconsin facility.
 
Goodwill — Goodwill is not amortized, but is required to be evaluated for impairment annually or whenever events or changes in circumstances suggest that the carrying value of an asset may not be recoverable. The Company evaluates goodwill for impairment annually in the fourth fiscal quarter and additionally on an interim basis if an event occurs or there is a change in circumstances, such as a decline in the Company’s stock price or a material adverse change in the business climate, which would more likely than not reduce the fair value of the reporting unit below its carrying amount. No such event or change in circumstances occurred; therefore, no changes in goodwill were made during the three months ended March 31, 2017 and 2016.
 
In January 2017, the FASB issued ASU No. 2017-04, Simplifying the Test for Goodwill. The standard streamlines the methodology for calculating whether goodwill is impaired based upon whether the carrying amount of goodwill exceeds the reporting unit’s fair value. ASU 2017-04 applies to public business entities and those other entities that have goodwill reported in their financial statements and have not elected the private company alternative for the subsequent measurement of goodwill and is effective for annual and interim reporting periods beginning after December 15, 2019, with early adoption permitted. The Company does not expect that the adoption of this standard will have a material effect on its financial statements.
 
Impairment of Long-Lived Assets — Long-lived assets other than goodwill consist primarily of fixed assets, which we periodically evaluate for potential impairment. Whenever events or circumstances change, an assessment is made as to whether there has been an impairment in the value of long-lived assets by determining whether projected undiscounted cash flows generated by the applicable asset exceed its net book value as of the assessment date. No such event or change in circumstances occurred; therefore, no such impairment occurred during the three months ended March 31, 2017 and 2016.
 
Stock-Based Compensation — The Company uses the Black-Scholes option-pricing model to calculate the grant-date fair value of stock option awards. The resulting compensation expense, net of expected forfeitures, for awards that are not performance-based is recognized on a straight-line basis over the service period of the award, which is generally three years for stock options. For stock options with performance-based vesting provisions, recognition of compensation expense, net of expected forfeitures, commences if and when the achievement of the performance criteria is deemed probable. The compensation expense, net of expected forfeitures, for performance-based stock options is recognized over the relevant performance period. Awards of stock that are not performance-based are valued at the fair market value on the date of the grant and are amortized over the service period of the award. Non-employee stock-based compensation is accounted for in accordance with the guidance of Financial Accounting Standards Board Accounting Standards Codification (“FASB ASC”) Topic 505, Equity.  As such, the Company recognizes expense based on the estimated fair value of options granted to non-employees over their vesting period, which is generally the period during which services are rendered and deemed completed by such non-employees.
 
Fair Value of Financial Instruments — The guidance under FASB ASC Topic 825, Financial Instruments, requires disclosure of the fair value of certain financial instruments. Financial instruments in the accompanying financial statements consist of cash equivalents, accounts payable and long-term obligations.  The carrying amount of cash equivalents and accounts payable approximate their fair value due to their short-term nature.  The carrying value of remaining long-term obligations, including the current portion, approximates fair value because the fixed interest rate approximates current market interest rates available on similar instruments.
 
Derivative Instruments — The Company generally does not use derivative instruments to hedge exposures to cash flow or market risks.  However, certain warrants to purchase common stock that do not meet the requirements for classification as equity, in accordance with the Derivatives and Hedging Topic of the FASB ASC, are classified as liabilities.  In such instances, net-cash settlement is assumed for financial reporting purposes, even when the terms of the underlying contracts do not provide for a net-cash settlement. These warrants are considered derivative instruments because the agreements contain a certain type of cash settlement feature, “down-round” provisions whereby the number of shares for which the warrants are exercisable and/or the exercise price of the warrants is subject to change in the event of certain issuances of stock at prices below the then-effective exercise price of the warrants. The number of shares issuable under such warrants was 533,065 at March 31, 2017 and December 31, 2016. The primary underlying risk exposure pertaining to the warrants is the change in fair value of the underlying common stock.  Such financial instruments are initially recorded at fair value with subsequent changes in fair value recorded as a component of gain or loss on derivatives on the consolidated statements of operations in each reporting period. If these instruments subsequently meet the requirements for equity classification, the Company reclassifies the fair value to equity. At March 31, 2017 and December 31, 2016, these warrants represented the only outstanding derivative instruments issued or held by the Company.
 
Leases — In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) which supersedes FASB ASC Topic 840, Leases (Topic 840) and provides principles for the recognition, measurement, presentation and disclosure of leases for both lessees and lessors. The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight-line basis over the term of the lease, respectively. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than twelve months regardless of classification. Leases with a term of twelve months or less will be accounted for similar to existing guidance for operating leases. The standard is effective for annual and interim periods beginning after December 15, 2018, with early adoption permitted upon issuance. The Company is currently evaluating the method of adoption and the impact of adopting ASU 2016-02 on its results of operations, cash flows and financial position.
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.7.0.1
FAIR VALUE
 3 Months Ended
Mar. 31, 2017
Fair Value Disclosures [Abstract]  
Fair Value Disclosures [Text Block]
2. FAIR VALUE
 
In accordance with Fair Value Measurements and Disclosures Topic of the FASB ASC 820, the Company groups its financial assets and financial liabilities generally measured at fair value in three levels, based on the markets in which the assets and liabilities are traded and the reliability of the assumptions used to determine fair value.
 
 
⋅
Level 1: Input prices quoted in an active market for identical financial assets or liabilities.
 
⋅
Level 2: Inputs other than prices quoted in Level 1, such as prices quoted for similar financial assets and liabilities in active markets, prices for identical assets, and liabilities in markets that are not active or other inputs that are observable or can be corroborated by observable market data.
 
⋅
Level 3: Input prices quoted that are significant to the fair value of the financial assets or liabilities which are not observable or supported by an active market.
  
To the extent that the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for instruments categorized in Level 3. A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.
 
The Company issued warrants to purchase an aggregate of 82,500 common shares in a February 2013 public offering (the “February 2013 Public Offering Warrants”). On February 20, 2014, 27,500 of the February 2013 Public Offering Warrants expired. On May 20, 2016, 16,250 warrants were exercised. The remaining 38,750 warrants are classified within the Level 3 hierarchy.
 
In August 2014, as part of an underwritten public offering, the Company issued 494,315 warrants to purchase common stock (the “August 2014 Warrants”). The August 2014 Warrants are listed on the NASDAQ Capital Market under the symbol “CLRBW,” however, there are certain periods where trading volume is low; therefore, they are classified as Level 2 within the hierarchy.
 
The following tables set forth the Company’s financial instruments carried at fair value using the lowest level of input applicable to each financial instrument as of March 31, 2017 and December 31, 2016:
 
 
 
March 31, 2017
 
 
 
Level 1
 
Level 2
 
Level 3
 
Fair Value
 
 
 
 
 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
February 2013 Public Offering Warrants
 
$
—
 
$
—
 
$
49,600
 
$
49,600
 
August 2014 Warrants
 
 
—
 
 
160,000
 
 
—
 
 
160,000
 
Total
 
$
—
 
$
160,000
 
$
49,600
 
$
209,600
 
 
 
 
December 31, 2016
 
 
 
Level 1
 
Level 2
 
Level 3
 
Fair Value
 
 
 
 
 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
February 2013 Public Offering Warrants
 
$
—
 
$
—
 
$
27,125
 
$
27,125
 
August 2014 Warrants
 
 
—
 
 
100,000
 
 
—
 
 
100,000
 
Total
 
$
—
 
$
100,000
 
$
27,125
 
$
127,125
 
 
In order to estimate the value of the February 2013 Public Offering Warrants considered to be derivative instruments, the Company uses a modified option-pricing model together with assumptions that consider, among other variables, the fair value of the underlying stock, risk-free interest rates, volatility, the contractual term of the warrants, future financing requirements and dividend rates. The future financing estimates are based on the Company’s estimates of anticipated cash requirements over the term of the warrants as well as the frequency of required financings based on its assessment of its historical financing trends and anticipated future events. Due to the nature of these inputs and the valuation technique utilized, these warrants are classified within the Level 3 hierarchy.
 
The following table summarizes the modified option-pricing assumptions used:
 
 
 
Three Months
 
Twelve Months
 
 
 
Ended
 
Ended
 
 
 
March 31,
 
December 31,
 
 
 
2017
 
2016
 
Volatility
 
 
118
%
 
92.72-134
%
Risk-free interest rate
 
 
1.03
%
 
0.53-1.15
%
Expected life (years)
 
 
0.89
 
 
1.14-1.89
 
Dividend
 
 
0
%
 
0
%
 
During fiscal year 2016, the Company had warrants outstanding for part of the year that were considered financial instruments. Those warrants were either extinguished or amended such that they were no longer considered financial instruments as of December 31, 2016, and were, therefore, not financial instruments during the quarter ended March 31, 2017. The following table summarizes the modified option-pricing assumptions used for the period they were considered financial instruments:
 
 
 
Twelve Months
 
 
 
Ended
 
 
 
December 31,
 
 
 
2016
 
Volatility
 
 
89.73
%
Risk-free interest rate
 
 
1.65
%
Expected life (years)
 
 
4.50
 
Dividend
 
 
0
%
 
The following table summarizes the changes in the fair market value of the Company’s warrants which are classified within the Level 3 fair value hierarchy.
 
 
 
Three Months
 
Twelve Months
 
 
 
Ended
 
Ended
 
 
 
March 31,
 
December 31,
 
 
 
2017
 
2016
 
Beginning balance – Fair value
 
$
27,125
 
$
2,067,000
 
Reclassification to equity for warrants that are no longer derivative liabilities
 
 
—
 
 
(1,392,429)
 
Loss (gain) on derivatives resulting from change in fair value or extinguishment
 
 
22,475
 
 
(647,446)
 
Ending balance – Fair value
 
$
49,600
 
$
27,125
 
 
To estimate the fair value of the August 2014 Warrants, the Company calculated the weighted average closing price for the trailing 10 day period with trades that ended on the balance sheet date.
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.7.0.1
STOCKHOLDERS' EQUITY
 3 Months Ended
Mar. 31, 2017
Equity [Abstract]  
Stockholders' Equity Note Disclosure [Text Block]
3. STOCKHOLDERS’ EQUITY
 
November 2016 Underwritten Offering
 
On November 23, 2016, the Company entered into an Underwriting Agreement with Ladenburg Thalmann & Co. Inc., as representative of the several underwriters named therein, in connection with the Company’s Registration Statement on Form S-1. Pursuant to the Underwriting Agreement, the Company agreed to sell to the Underwriter 800,000 shares of common stock, 68 shares of Series A preferred stock convertible into 4,533,356 shares of common stock and Series C warrants to purchase 5,333,356 shares of common stock, plus up to an additional 800,000 shares of common stock and Series C warrants to purchase up to an additional 800,000 shares of common stock in the event of the exercise by the Underwriter of its over-allotment option. The public offering price of a share of common stock together with a Series C warrant to purchase one share of common stock was $1.50. The public offering price to purchase one share of Series A preferred stock, each of which is convertible into 66,667 shares of common stock, together with a Series C warrant to purchase 66,667 shares of common stock was $100,000. The preferred stock was non-voting, had no dividend rights (except to the extent dividends were also paid on common stock), liquidation preference, or other preferences over common stock. The Series C warrants have an exercise price of $1.50 per share, and are exercisable for five years from the date of issuance. The net proceeds were allocated to each security based upon the pro-rata values of the underlying common stock and a Black-Scholes valuation of the warrants.
 
The sale of securities pursuant to the Underwriting Agreement, including the entire over-allotment option, closed on November 29, 2016 (the “November 2016 Underwritten Offering”). Gross proceeds were $9.2 million with net proceeds to the Company of approximately $8.3 million.
 
As of December 31, 2016, 17 shares of Series A preferred stock were outstanding. During the three months ended March 31, 2017, all 17 shares were converted into 1,133,339 shares of common stock.
 
During the three months ended March 31, 2017, Series C warrants representing 1,956,506 shares of common stock were exercised by the holders, for proceeds of $2,934,759.
 
April 2016 Underwritten Offering
 
On April 15, 2016, the Company entered into an Underwriting Agreement with Ladenburg Thalmann & Co., Inc. in connection with the Company’s Registration Statement on Form S-1. Pursuant to the Underwriting Agreement, the Company agreed to sell to the Underwriter 1,378,364 shares of common stock, Series B prefunded warrants to purchase 1,908,021 shares of common stock and Series A warrants to purchase 3,286,385 shares of common stock, plus up to an additional 492,957 shares of common stock and Series A warrants to purchase up to an additional 492,957 shares of common stock in the event of the exercise by the Underwriter of its over-allotment option. The public offering price of a share of common stock together with a Series A warrant to purchase one share of common stock was $2.13. The public offering price of a Series B pre-funded warrant to purchase one share of common stock together with a Series A warrant to purchase one share of common stock was $2.12. The Series B pre-funded warrants had an exercise price of $0.01 per share, were immediately exercisable and do not expire. The Series A warrants have an exercise price of $3.04 per share, are exercisable for five years from the date of issuance, and are callable by the Company under certain circumstances.
 
On April 20, 2016, the Company closed on the underwritten public offering (the “April 2016 Underwritten Offering”) of 1,871,321 shares of its common stock and Series B pre-funded warrants to purchase 1,908,021 shares of common stock, plus the issuance of Series A warrants to purchase 3,779,342 shares of common stock, reflecting the exercise in full of the Underwriter’s over-allotment option. The gross proceeds of the offering amounted to approximately $8.0 million with net proceeds to the Company of approximately $7.2 million.
 
Warrant Restructuring
 
On April 13, 2016, the Company entered into an exchange and amendment agreement (the “Warrant Restructuring Agreement”). Pursuant to the Warrant Restructuring Agreement, the Company agreed with the holders of 2015 Series A warrants that upon the consummation of the 2016 Underwritten Offering, the exercise price of the 2015 Series A warrants would be reduced to the public offering price per share of the shares of common stock sold in this offering and that the warrants would be amended such that the exercise price would no longer be subject to adjustment in connection with future equity offerings we may undertake. In consideration of this amendment, the Company agreed to issue to each of those holders a new warrant to purchase an additional number of shares of common stock equal to twice the number of shares of common stock underlying the 2015 Series A Warrants held by them (the “Incremental Series A Warrants”). As a result, the 2015 Series A warrants and the Incremental Series A Warrants have an exercise price equal to $2.13 (the public offering price of the shares of common stock sold in the 2016 Underwritten Offering).
 
2016 Reverse Stock Split and Recapitalization
 
At a special meeting held on February 8, 2016, the Company’s stockholders approved an amendment to the Company’s certificate of incorporation to effect a reverse split of the Company’s common stock at a ratio between 1:5 to 1:10 in order to ensure that adequate authorized but unissued shares would be available for anticipated future financings, and to satisfy requirements for the continued listing of the Company’s common stock on the NASDAQ Capital Market. In addition, the proposal approved by the stockholders provided that if the reverse split was effected, the number of shares of common stock that the Company is authorized to issue remained unchanged at 40,000,000. The Company’s stockholders further authorized the board of directors to determine the ratio at which the reverse split would be effected by filing an appropriate amendment to the Company’s certificate of incorporation. The board of directors authorized the ratio of the reverse split on February 24, 2016, and effective at the close of business on March 4, 2016, the Company’s certificate of incorporation was amended to effect a 1-for-10 reverse split of the Company’s common stock (the “2016 Reverse Split”). All share and per share numbers included in these consolidated financial statements give effect to the 2016 Reverse Split.
 
Common Stock Warrants
 
The following table summarizes information with regard to outstanding warrants to purchase common stock as of March 31, 2017.
 
 
 
Number of Shares
 
 
 
 
 
 
 
 
Issuable Upon
 
 
 
 
 
 
 
 
Exercise of
 
 
 
 
 
 
 
 
Outstanding
 
 
Exercise
 
 
 
Offering
 
Warrants
 
 
Price
 
 
Expiration Date
 
 
 
 
 
 
 
 
 
November 2016 Public Offering Series C
 
 
4,176,850
 
 
$
1.50
 
 
November 29, 2021
April 2016 Underwritten Registered Series A
 
 
3,626,942
 
 
$
3.04
 
 
April 20, 2021
October 2015 Incremental Series A
 
 
300,006
 
 
$
2.13
 
 
October 20, 2021
October 2015 Private Placement Series A
 
 
86,365
 
 
$
2.13
 
 
April 1, 2021
October 2015 Offering – Placement Agent
 
 
3,750
 
 
$
28.30
 
 
October 1, 2020
August 2014 Public Offering (1)
 
 
504,019
 
 
$
46.80
 
 
August 20, 2019
February 2013 Public Offering (1)
 
 
38,750
 
 
$
1.50
(2)
 
February 20, 2018
February 2013 Public Offering – Placement Agents
 
 
3,854
 
 
$
125.00
 
 
February 4, 2018
November 2012 Private Placement
 
 
5,000
 
 
$
250.00
 
 
November 2, 2017
June 2012 Public Offering
 
 
14,910
 
 
$
250.00
 
 
June 13, 2017
Total
 
 
8,760,446
 
 
 
 
 
 
 
 
(1)
These warrants have a certain type of cash settlement feature or their exercise prices for which the warrant may be exercised are subject to adjustment for “down-rounds” and the warrants have been accounted for as derivative instruments as described in Note 3, with the exception of 9,704 warrants issued in August 2014.
 
(2)
Due to the issuance of common stock at $1.50 per share as part of the November 2016 Underwritten Offering, the remaining outstanding warrants issued as part of the February 2013 Public Offering were adjusted to reflect the revised exercise price of $1.50 each.
 
Reserved Shares
 
The following shares were reserved for future issuance upon exercise of stock options, preferred stock conversions and warrants:
 
 
 
March 31,
 
December 31,
 
 
 
2017
 
2016
 
 
 
 
 
 
 
Warrants
 
 
8,760,446
 
 
10,716,952
 
Preferred stock
 
 
—
 
 
1,133,339
 
Stock options
 
 
508,733
 
 
471,433
 
Total number of shares reserved for future issuance
 
 
9,269,179
 
 
12,321,724
 
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.7.0.1
NOTES PAYABLE
 3 Months Ended
Mar. 31, 2017
Debt Disclosure [Abstract]  
Notes Payable Disclosure [Text Block]
4. NOTES PAYABLE
 
During the quarter ended March 31, 2017, the two loans with initial principal amounts totaling $450,000 from the Wisconsin Economic Development Corporation, dated September 15, 2010, were paid in full.
XML 20 R10.htm IDEA: XBRL DOCUMENT v3.7.0.1
STOCK-BASED COMPENSATION
 3 Months Ended
Mar. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
5. STOCK-BASED COMPENSATION
 
Accounting for Stock-Based Compensation
The following table summarizes amounts charged to expense for stock-based compensation related to employee and director stock option grants and recorded in connection with stock options granted to non-employee consultants:
 
 
 
Three Months Ended
 
 
 
March 31,
 
 
 
2017
 
2016
 
 
 
 
 
 
 
Employee and director stock option grants:
 
 
 
 
 
 
 
Research and development
 
$
16,648
 
$
11,035
 
General and administrative
 
 
149,026
 
 
92,249
 
 
 
 
165,674
 
 
103,284
 
 
 
 
 
 
 
 
 
Non-employee consultant stock option grants:
 
 
 
 
 
 
 
Research and development
 
 
—
 
 
(366)
 
 
 
 
—
 
 
(366)
 
 
 
 
 
 
 
 
 
Total stock-based compensation
 
$
165,674
 
$
102,918
 
 
Assumptions Used In Determining Fair Value
 
Valuation and amortization method. The fair value of each stock award is estimated on the grant date using the Black-Scholes option-pricing model.  The estimated fair value of employee stock options is amortized to expense using the straight-line method over the vesting period. The estimated fair value of the non-employee options is amortized to expense over the period during which a non-employee is required to provide services for the award (usually the vesting period).
 
Volatility. The Company estimates volatility based on an average of (1) the Company’s historical volatility since its common stock has been publicly traded and (2) review of volatility estimates of publicly held drug development companies with similar market capitalizations.
 
Risk-free interest rate. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant commensurate with the expected term assumption.
 
Expected term. The expected term of stock options granted is based on an estimate of when options will be exercised in the future. The Company applied the simplified method of estimating the expected term of the options, as described in the SEC’s Staff Accounting Bulletins 107 and 110, as the historical experience is not indicative of the expected behavior in the future. The expected term, calculated under the simplified method, is applied to groups of stock options that have similar contractual terms. Using this method, the expected term is determined using the average of the vesting period and the contractual life of the stock options granted. The Company applied the simplified method to non-employees who have a truncation of term based on termination of service and utilizes the contractual life of the stock options granted for those non-employee grants which do not have a truncation of service.
 
Forfeitures. The Company records stock-based compensation expense only for those awards that are expected to vest. A forfeiture rate is estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from initial estimates. An annual forfeiture rate of 2% was applied to all unvested options for employees and directors, respectively, for the three months ended March 31, 2017 and for the year ended December 31, 2016.  Ultimately, the actual expense recognized over the vesting period will be for only those shares that vest.
 
Exercise prices for all grants made during the three months ended March 31, 2017 were equal to the market value of the Company’s common stock on the date of grant. There were no stock option grants during the three months ended March 31, 2016.
 
Stock Option Activity
 
A summary of stock option activity is as follows:
 
 
 
 
 
 
 
 
 
Weighted
 
 
 
 
 
 
Number of
 
 
 
 
 
Average
 
 
 
 
 
 
Shares Issuable
 
 
 
 
 
Remaining
 
 
 
 
 
 
Upon Exercise
 
 
Weighted
 
 
Contracted
 
 
Aggregate
 
 
 
of Outstanding
 
 
Average
 
 
Term in
 
 
Intrinsic
 
 
 
Options
 
 
Exercise Price
 
 
Years
 
 
Value
 
Outstanding at December 31, 2016
 
 
471,433
 
 
$
7.59
 
 
 
 
 
 
 
 
 
Granted
 
 
37,300
 
 
$
2.18
 
 
 
 
 
 
 
 
 
Expired
 
 
—
 
 
$
—
 
 
 
 
 
 
 
 
 
Forfeited
 
 
—
 
 
$
—
 
 
 
 
 
 
 
 
 
Outstanding at March 31, 2017
 
 
508,733
 
 
$
7.19
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Vested, March 31, 2017
 
 
104,106
 
 
$
19.84
 
 
 
8.70
 
 
$
54,579
 
Unvested, March 31, 2017
 
 
404,627
 
 
$
3.94
 
 
 
9.17
 
 
$
167,134
 
Exercisable at March 31, 2017
 
 
104,106
 
 
$
19.84
 
 
 
8.70
 
 
$
54,579
 
 
The aggregate intrinsic value of options outstanding is calculated based on the positive difference between the estimated per-share fair value of common stock at the end of the respective period and the exercise price of the underlying options.  There have been no option exercises to date. Shares of common stock issued upon the exercise of options are from authorized but unissued shares.
 
As of March 31, 2017, there was approximately $950,882 of total unrecognized compensation cost related to unvested stock-based compensation arrangements.  Of this total amount, the Company expects to recognize approximately $372,648, $391,798, $186,079, and $357 during 2017, 2018, 2019 and 2020, respectively. The Company’s expense estimates are based upon the expectation that all unvested options will vest in the future, less the forfeiture rate discussed above. The weighted-average grant-date fair value of vested and unvested options outstanding at March 31, 2017 was $14.95 and $3.20, respectively.
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.7.0.1
INCOME TAXES
 3 Months Ended
Mar. 31, 2017
Income Tax Disclosure [Abstract]  
Income Tax Disclosure [Text Block]
6.  INCOME TAXES
 
The Company accounts for income taxes in accordance with the liability method of accounting. Deferred tax assets or liabilities are computed based on the difference between the financial statement and income tax basis of assets and liabilities, and net operating loss carryforwards, (NOLs) using the enacted tax rates. Deferred income tax expense or benefit is based on changes in the asset or liability from period to period. The Company did not record a provision or benefit for federal, state or foreign income taxes for the three months ended March 31, 2017 or 2016 because the Company has experienced losses on a tax basis since inception. Because of the limited operating history, continuing losses and uncertainty associated with the utilization of the NOLs in the future, management has provided a full allowance against the value of its gross deferred tax assets.
 
The Company also accounts for the uncertainty in income taxes related to the recognition and measurement of a tax position taken or expected to be taken in an income tax return. The Company follows the applicable accounting guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition related to the uncertainty in income tax positions. No uncertain tax positions have been identified.
XML 22 R12.htm IDEA: XBRL DOCUMENT v3.7.0.1
NET INCOME (LOSS) PER SHARE
 3 Months Ended
Mar. 31, 2017
Earnings Per Share [Abstract]  
Earnings Per Share [Text Block]
7. NET INCOME (LOSS) PER SHARE
 
Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. Diluted net income per share for the three months ended March 31, 2016 is computed by dividing net income by the sum of the weighted average number of shares of common stock and the dilutive potential common stock equivalents then outstanding.  Potential common stock equivalents consist of stock options and warrants. Since there is a net loss attributable to common stockholders for the three months ended March 31, 2017, the inclusion of common stock equivalents in the computation for that period would be antidilutive.
 
The following potentially dilutive securities have been excluded from the computation of diluted net income (loss) per share since their inclusion would be antidilutive:
 
 
 
Three Months Ended March 31,
 
 
 
2017
 
2016
 
Warrants
 
 
8,760,446
 
 
782,782
 
Stock options
 
 
508,733
 
 
68,582
 
XML 23 R13.htm IDEA: XBRL DOCUMENT v3.7.0.1
COMMITMENTS AND CONTINGENCIES
 3 Months Ended
Mar. 31, 2017
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Disclosure [Text Block]
8.  COMMITMENTS AND CONTINGENCIES
 
The Company is involved in legal matters and disputes in the ordinary course of business. We do not anticipate that the outcome of such matters and disputes will materially affect the Company’s financial statements.
XML 24 R14.htm IDEA: XBRL DOCUMENT v3.7.0.1
NATURE OF BUSINESS, ORGANIZATION AND GOING CONCERN (Policies)
 3 Months Ended
Mar. 31, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Consolidation, Policy [Policy Text Block]
Principles of Consolidation — The consolidated financial statements include the accounts of the Company and the accounts of its wholly-owned subsidiary. All significant intercompany accounts and transactions have been eliminated.
Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]
Restricted Cash — The Company accounts for cash that is restricted for other than current operations as restricted cash. Restricted cash at March 31, 2017 and December 31, 2016 consisted of a certificate of deposit of $55,000 required under the Company’s lease agreement for its Madison, Wisconsin facility.
Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]
Goodwill — Goodwill is not amortized, but is required to be evaluated for impairment annually or whenever events or changes in circumstances suggest that the carrying value of an asset may not be recoverable. The Company evaluates goodwill for impairment annually in the fourth fiscal quarter and additionally on an interim basis if an event occurs or there is a change in circumstances, such as a decline in the Company’s stock price or a material adverse change in the business climate, which would more likely than not reduce the fair value of the reporting unit below its carrying amount. No such event or change in circumstances occurred; therefore, no changes in goodwill were made during the three months ended March 31, 2017 and 2016.
 
In January 2017, the FASB issued ASU No. 2017-04, Simplifying the Test for Goodwill. The standard streamlines the methodology for calculating whether goodwill is impaired based upon whether the carrying amount of goodwill exceeds the reporting unit’s fair value. ASU 2017-04 applies to public business entities and those other entities that have goodwill reported in their financial statements and have not elected the private company alternative for the subsequent measurement of goodwill and is effective for annual and interim reporting periods beginning after December 15, 2019, with early adoption permitted. The Company does not expect that the adoption of this standard will have a material effect on its financial statements.
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]
Impairment of Long-Lived Assets — Long-lived assets other than goodwill consist primarily of fixed assets, which we periodically evaluate for potential impairment. Whenever events or circumstances change, an assessment is made as to whether there has been an impairment in the value of long-lived assets by determining whether projected undiscounted cash flows generated by the applicable asset exceed its net book value as of the assessment date. No such event or change in circumstances occurred; therefore, no such impairment occurred during the three months ended March 31, 2017 and 2016.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]
Stock-Based Compensation — The Company uses the Black-Scholes option-pricing model to calculate the grant-date fair value of stock option awards. The resulting compensation expense, net of expected forfeitures, for awards that are not performance-based is recognized on a straight-line basis over the service period of the award, which is generally three years for stock options. For stock options with performance-based vesting provisions, recognition of compensation expense, net of expected forfeitures, commences if and when the achievement of the performance criteria is deemed probable. The compensation expense, net of expected forfeitures, for performance-based stock options is recognized over the relevant performance period. Awards of stock that are not performance-based are valued at the fair market value on the date of the grant and are amortized over the service period of the award. Non-employee stock-based compensation is accounted for in accordance with the guidance of Financial Accounting Standards Board Accounting Standards Codification (“FASB ASC”) Topic 505, Equity.  As such, the Company recognizes expense based on the estimated fair value of options granted to non-employees over their vesting period, which is generally the period during which services are rendered and deemed completed by such non-employees.
Fair Value of Financial Instruments, Policy [Policy Text Block]
Fair Value of Financial Instruments — The guidance under FASB ASC Topic 825, Financial Instruments, requires disclosure of the fair value of certain financial instruments. Financial instruments in the accompanying financial statements consist of cash equivalents, accounts payable and long-term obligations.  The carrying amount of cash equivalents and accounts payable approximate their fair value due to their short-term nature.  The carrying value of remaining long-term obligations, including the current portion, approximates fair value because the fixed interest rate approximates current market interest rates available on similar instruments.
Derivatives, Policy [Policy Text Block]
Derivative Instruments — The Company generally does not use derivative instruments to hedge exposures to cash flow or market risks.  However, certain warrants to purchase common stock that do not meet the requirements for classification as equity, in accordance with the Derivatives and Hedging Topic of the FASB ASC, are classified as liabilities.  In such instances, net-cash settlement is assumed for financial reporting purposes, even when the terms of the underlying contracts do not provide for a net-cash settlement. These warrants are considered derivative instruments because the agreements contain a certain type of cash settlement feature, “down-round” provisions whereby the number of shares for which the warrants are exercisable and/or the exercise price of the warrants is subject to change in the event of certain issuances of stock at prices below the then-effective exercise price of the warrants. The number of shares issuable under such warrants was 533,065 at March 31, 2017 and December 31, 2016. The primary underlying risk exposure pertaining to the warrants is the change in fair value of the underlying common stock.  Such financial instruments are initially recorded at fair value with subsequent changes in fair value recorded as a component of gain or loss on derivatives on the consolidated statements of operations in each reporting period. If these instruments subsequently meet the requirements for equity classification, the Company reclassifies the fair value to equity. At March 31, 2017 and December 31, 2016, these warrants represented the only outstanding derivative instruments issued or held by the Company.
Lease, Policy [Policy Text Block]
Leases — In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) which supersedes FASB ASC Topic 840, Leases (Topic 840) and provides principles for the recognition, measurement, presentation and disclosure of leases for both lessees and lessors. The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight-line basis over the term of the lease, respectively. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than twelve months regardless of classification. Leases with a term of twelve months or less will be accounted for similar to existing guidance for operating leases. The standard is effective for annual and interim periods beginning after December 15, 2018, with early adoption permitted upon issuance. The Company is currently evaluating the method of adoption and the impact of adopting ASU 2016-02 on its results of operations, cash flows and financial position.
XML 25 R15.htm IDEA: XBRL DOCUMENT v3.7.0.1
FAIR VALUE (Tables)
 3 Months Ended
Mar. 31, 2017
Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]
The following tables set forth the Company’s financial instruments carried at fair value using the lowest level of input applicable to each financial instrument as of March 31, 2017 and December 31, 2016:
 
 
 
March 31, 2017
 
 
 
Level 1
 
Level 2
 
Level 3
 
Fair Value
 
 
 
 
 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
February 2013 Public Offering Warrants
 
$
—
 
$
—
 
$
49,600
 
$
49,600
 
August 2014 Warrants
 
 
—
 
 
160,000
 
 
—
 
 
160,000
 
Total
 
$
—
 
$
160,000
 
$
49,600
 
$
209,600
 
 
 
 
December 31, 2016
 
 
 
Level 1
 
Level 2
 
Level 3
 
Fair Value
 
 
 
 
 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
February 2013 Public Offering Warrants
 
$
—
 
$
—
 
$
27,125
 
$
27,125
 
August 2014 Warrants
 
 
—
 
 
100,000
 
 
—
 
 
100,000
 
Total
 
$
—
 
$
100,000
 
$
27,125
 
$
127,125
 
Schedule Of Changes In Fair Value Warrants Classified Level Three [Table Text Block]
The following table summarizes the changes in the fair market value of the Company’s warrants which are classified within the Level 3 fair value hierarchy.
 
 
 
Three Months
 
Twelve Months
 
 
 
Ended
 
Ended
 
 
 
March 31,
 
December 31,
 
 
 
2017
 
2016
 
Beginning balance – Fair value
 
$
27,125
 
$
2,067,000
 
Reclassification to equity for warrants that are no longer derivative liabilities
 
 
—
 
 
(1,392,429)
 
Loss (gain) on derivatives resulting from change in fair value or extinguishment
 
 
22,475
 
 
(647,446)
 
Ending balance – Fair value
 
$
49,600
 
$
27,125
 
2013 Warrants [Member]  
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Table Text Block]
The following table summarizes the modified option-pricing assumptions used:
 
 
 
Three Months
 
Twelve Months
 
 
 
Ended
 
Ended
 
 
 
March 31,
 
December 31,
 
 
 
2017
 
2016
 
Volatility
 
 
118
%
 
92.72-134
%
Risk-free interest rate
 
 
1.03
%
 
0.53-1.15
%
Expected life (years)
 
 
0.89
 
 
1.14-1.89
 
Dividend
 
 
0
%
 
0
%
2015 Warrants [Member]  
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Table Text Block]
The following table summarizes the modified option-pricing assumptions used for the period they were considered financial instruments:
 
 
 
Twelve Months
 
 
 
Ended
 
 
 
December 31,
 
 
 
2016
 
Volatility
 
 
89.73
%
Risk-free interest rate
 
 
1.65
%
Expected life (years)
 
 
4.50
 
Dividend
 
 
0
%
XML 26 R16.htm IDEA: XBRL DOCUMENT v3.7.0.1
STOCKHOLDERS' EQUITY (Tables)
 3 Months Ended
Mar. 31, 2017
Equity [Abstract]  
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]
The following table summarizes information with regard to outstanding warrants to purchase common stock as of March 31, 2017.
 
 
 
Number of Shares
 
 
 
 
 
 
 
 
Issuable Upon
 
 
 
 
 
 
 
 
Exercise of
 
 
 
 
 
 
 
 
Outstanding
 
 
Exercise
 
 
 
Offering
 
Warrants
 
 
Price
 
 
Expiration Date
 
 
 
 
 
 
 
 
 
November 2016 Public Offering Series C
 
 
4,176,850
 
 
$
1.50
 
 
November 29, 2021
April 2016 Underwritten Registered Series A
 
 
3,626,942
 
 
$
3.04
 
 
April 20, 2021
October 2015 Incremental Series A
 
 
300,006
 
 
$
2.13
 
 
October 20, 2021
October 2015 Private Placement Series A
 
 
86,365
 
 
$
2.13
 
 
April 1, 2021
October 2015 Offering – Placement Agent
 
 
3,750
 
 
$
28.30
 
 
October 1, 2020
August 2014 Public Offering (1)
 
 
504,019
 
 
$
46.80
 
 
August 20, 2019
February 2013 Public Offering (1)
 
 
38,750
 
 
$
1.50
(2)
 
February 20, 2018
February 2013 Public Offering – Placement Agents
 
 
3,854
 
 
$
125.00
 
 
February 4, 2018
November 2012 Private Placement
 
 
5,000
 
 
$
250.00
 
 
November 2, 2017
June 2012 Public Offering
 
 
14,910
 
 
$
250.00
 
 
June 13, 2017
Total
 
 
8,760,446
 
 
 
 
 
 
 
 
(1)
These warrants have a certain type of cash settlement feature or their exercise prices for which the warrant may be exercised are subject to adjustment for “down-rounds” and the warrants have been accounted for as derivative instruments as described in Note 3, with the exception of 9,704 warrants issued in August 2014.
 
(2)
Due to the issuance of common stock at $1.50 per share as part of the November 2016 Underwritten Offering, the remaining outstanding warrants issued as part of the February 2013 Public Offering were adjusted to reflect the revised exercise price of $1.50 each.
Reserved For Future Issuance Upon Exercise Of Stock Options And Warrants Or Conversion Of Debt Text Block [Table Text Block]
The following shares were reserved for future issuance upon exercise of stock options, preferred stock conversions and warrants:
 
 
 
March 31,
 
December 31,
 
 
 
2017
 
2016
 
 
 
 
 
 
 
Warrants
 
 
8,760,446
 
 
10,716,952
 
Preferred stock
 
 
—
 
 
1,133,339
 
Stock options
 
 
508,733
 
 
471,433
 
Total number of shares reserved for future issuance
 
 
9,269,179
 
 
12,321,724
 
XML 27 R17.htm IDEA: XBRL DOCUMENT v3.7.0.1
STOCK-BASED COMPENSATION (Tables)
 3 Months Ended
Mar. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan [Table Text Block]
The following table summarizes amounts charged to expense for stock-based compensation related to employee and director stock option grants and recorded in connection with stock options granted to non-employee consultants:
 
 
 
Three Months Ended
 
 
 
March 31,
 
 
 
2017
 
2016
 
 
 
 
 
 
 
Employee and director stock option grants:
 
 
 
 
 
 
 
Research and development
 
$
16,648
 
$
11,035
 
General and administrative
 
 
149,026
 
 
92,249
 
 
 
 
165,674
 
 
103,284
 
 
 
 
 
 
 
 
 
Non-employee consultant stock option grants:
 
 
 
 
 
 
 
Research and development
 
 
—
 
 
(366)
 
 
 
 
—
 
 
(366)
 
 
 
 
 
 
 
 
 
Total stock-based compensation
 
$
165,674
 
$
102,918
 
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]
A summary of stock option activity is as follows:
 
 
 
 
 
 
 
 
 
Weighted
 
 
 
 
 
 
Number of
 
 
 
 
 
Average
 
 
 
 
 
 
Shares Issuable
 
 
 
 
 
Remaining
 
 
 
 
 
 
Upon Exercise
 
 
Weighted
 
 
Contracted
 
 
Aggregate
 
 
 
of Outstanding
 
 
Average
 
 
Term in
 
 
Intrinsic
 
 
 
Options
 
 
Exercise Price
 
 
Years
 
 
Value
 
Outstanding at December 31, 2016
 
 
471,433
 
 
$
7.59
 
 
 
 
 
 
 
 
 
Granted
 
 
37,300
 
 
$
2.18
 
 
 
 
 
 
 
 
 
Expired
 
 
—
 
 
$
—
 
 
 
 
 
 
 
 
 
Forfeited
 
 
—
 
 
$
—
 
 
 
 
 
 
 
 
 
Outstanding at March 31, 2017
 
 
508,733
 
 
$
7.19
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Vested, March 31, 2017
 
 
104,106
 
 
$
19.84
 
 
 
8.70
 
 
$
54,579
 
Unvested, March 31, 2017
 
 
404,627
 
 
$
3.94
 
 
 
9.17
 
 
$
167,134
 
Exercisable at March 31, 2017
 
 
104,106
 
 
$
19.84
 
 
 
8.70
 
 
$
54,579
 
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.7.0.1
NET INCOME (LOSS) PER SHARE (Tables)
 3 Months Ended
Mar. 31, 2017
Earnings Per Share [Abstract]  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
The following potentially dilutive securities have been excluded from the computation of diluted net income (loss) per share since their inclusion would be antidilutive:
 
 
 
Three Months Ended March 31,
 
 
 
2017
 
2016
 
Warrants
 
 
8,760,446
 
 
782,782
 
Stock options
 
 
508,733
 
 
68,582
 
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.7.0.1
NATURE OF BUSINESS, ORGANIZATION AND GOING CONCERN (Details Textual) - USD ($)
 3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Dec. 31, 2016
Net Income (Loss) Attributable to Parent, Total $ 2,891,324 $ (824,563)  
Certificates of Deposit, at Carrying Value $ 55,000   $ 55,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options 533,065   533,065
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.7.0.1
FAIR VALUE (Details) - USD ($)
Mar. 31, 2017
Dec. 31, 2016
Liabilities:    
Derivative Liability, Current $ 209,600 $ 127,125
February 2013 Public Offering Warrants [Member]    
Liabilities:    
Derivative Liability, Current 49,600 27,125
August 2014 Warrants [Member]    
Liabilities:    
Derivative Liability, Current 160,000 100,000
Fair Value, Inputs, Level 1 [Member]    
Liabilities:    
Derivative Liability, Current 0 0
Fair Value, Inputs, Level 1 [Member] | February 2013 Public Offering Warrants [Member]    
Liabilities:    
Derivative Liability, Current 0 0
Fair Value, Inputs, Level 1 [Member] | August 2014 Warrants [Member]    
Liabilities:    
Derivative Liability, Current 0 0
Fair Value, Inputs, Level 2 [Member]    
Liabilities:    
Derivative Liability, Current 160,000 100,000
Fair Value, Inputs, Level 2 [Member] | February 2013 Public Offering Warrants [Member]    
Liabilities:    
Derivative Liability, Current 0 0
Fair Value, Inputs, Level 2 [Member] | August 2014 Warrants [Member]    
Liabilities:    
Derivative Liability, Current 160,000 100,000
Fair Value, Inputs, Level 3 [Member]    
Liabilities:    
Derivative Liability, Current 49,600 27,125
Fair Value, Inputs, Level 3 [Member] | February 2013 Public Offering Warrants [Member]    
Liabilities:    
Derivative Liability, Current 49,600 27,125
Fair Value, Inputs, Level 3 [Member] | August 2014 Warrants [Member]    
Liabilities:    
Derivative Liability, Current $ 0 $ 0
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.7.0.1
FAIR VALUE (Details 1) - 2013 Warrants [Member]
 3 Months Ended 12 Months Ended
Mar. 31, 2017
Dec. 31, 2016
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]    
Volatility 118.00%  
Risk-free interest rate 1.03%  
Expected life (years) 10 months 20 days  
Dividend 0.00% 0.00%
Maximum [Member]    
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]    
Volatility   134.00%
Risk-free interest rate   1.15%
Expected life (years)   1 year 10 months 20 days
Minimum [Member]    
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]    
Volatility   92.72%
Risk-free interest rate   0.53%
Expected life (years)   1 year 1 month 20 days
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.7.0.1
FAIR VALUE (Details 2) - Warrant [Member]
 12 Months Ended
Dec. 31, 2016
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]  
Volatility 89.73%
Risk-free interest rate 1.65%
Expected life (years) 4 years 6 months
Dividend 0.00%
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.7.0.1
FAIR VALUE (Details 3) - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Dec. 31, 2016
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Loss (gain) on derivatives resulting from change in fair value or extinguishment $ (82,475) $ 2,824,722  
Fair Value, Inputs, Level 3 [Member]      
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Beginning balance - Fair value 27,125 $ 2,067,000 $ 2,067,000
Reclassification to equity for warrants that are no longer derivative liabilities 0   (1,392,429)
Loss (gain) on derivatives resulting from change in fair value or extinguishment 22,475   (647,446)
Ending balance - Fair value $ 49,600   $ 27,125
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.7.0.1
FAIR VALUE (Details Textual) - shares
 1 Months Ended
May 20, 2016
Feb. 20, 2014
Mar. 31, 2017
Aug. 31, 2014
Feb. 28, 2013
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Class of Warrant or Right, Number of Securities Called by Warrants or Rights     8,760,446    
February 2013 Public Offering Warrants [Member]          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Class of Warrant or Right, Number of Securities Called by Warrants or Rights         82,500
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations   27,500      
Number Of Warrants Exercised 16,250        
February 2013 Public Offering Warrants [Member] | Fair Value, Inputs, Level 3 [Member]          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Class of Warrant or Right, Outstanding 38,750        
August 2014 Public Offering Warrants [Member]          
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]          
Class of Warrant or Right, Number of Securities Called by Warrants or Rights       494,315  
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.7.0.1
STOCKHOLDERS' EQUITY (Details)
 3 Months Ended
Mar. 31, 2017
$ / shares
shares
Class of Warrant or Right [Line Items]  
Number of Shares Issuable Upon Exercise of Outstanding Warrants (in shares) 8,760,446
November 2016 Public Offering Series C [Member]  
Class of Warrant or Right [Line Items]  
Number of Shares Issuable Upon Exercise of Outstanding Warrants (in shares) 4,176,850
Exercise Price (in dollars per share) | $ / shares $ 1.5
Warrants Expiration Date Nov. 29, 2021
April 2016 Underwritten Registered Series A [Member]  
Class of Warrant or Right [Line Items]  
Number of Shares Issuable Upon Exercise of Outstanding Warrants (in shares) 3,626,942
Exercise Price (in dollars per share) | $ / shares $ 3.04
Warrants Expiration Date Apr. 20, 2021
October 2015 Incremental Series A [Member]  
Class of Warrant or Right [Line Items]  
Number of Shares Issuable Upon Exercise of Outstanding Warrants (in shares) 300,006
Exercise Price (in dollars per share) | $ / shares $ 2.13
Warrants Expiration Date Oct. 20, 2021
October 2015 Private Placement Series A [Member]  
Class of Warrant or Right [Line Items]  
Number of Shares Issuable Upon Exercise of Outstanding Warrants (in shares) 86,365
Exercise Price (in dollars per share) | $ / shares $ 2.13
Warrants Expiration Date Apr. 01, 2021
October 2015 Offering - Placement Agent [Member]  
Class of Warrant or Right [Line Items]  
Number of Shares Issuable Upon Exercise of Outstanding Warrants (in shares) 3,750
Exercise Price (in dollars per share) | $ / shares $ 28.3
Warrants Expiration Date Oct. 01, 2020
August 2014 Public Offering [Member]  
Class of Warrant or Right [Line Items]  
Number of Shares Issuable Upon Exercise of Outstanding Warrants (in shares) 504,019 [1]
Exercise Price (in dollars per share) | $ / shares $ 46.8 [1]
Warrants Expiration Date Aug. 20, 2019 [1]
February 2013 Public Offering [Member]  
Class of Warrant or Right [Line Items]  
Number of Shares Issuable Upon Exercise of Outstanding Warrants (in shares) 38,750 [1]
Exercise Price (in dollars per share) | $ / shares $ 1.5 [1],[2]
Warrants Expiration Date Feb. 20, 2018 [1]
February 2013 Public Offering - Placement Agents [Member]  
Class of Warrant or Right [Line Items]  
Number of Shares Issuable Upon Exercise of Outstanding Warrants (in shares) 3,854
Exercise Price (in dollars per share) | $ / shares $ 125
Warrants Expiration Date Feb. 04, 2018
November 2012 Private Placement [Member]  
Class of Warrant or Right [Line Items]  
Number of Shares Issuable Upon Exercise of Outstanding Warrants (in shares) 5,000
Exercise Price (in dollars per share) | $ / shares $ 250
Warrants Expiration Date Nov. 02, 2017
June 2012 Public Offering [Member]  
Class of Warrant or Right [Line Items]  
Number of Shares Issuable Upon Exercise of Outstanding Warrants (in shares) 14,910
Exercise Price (in dollars per share) | $ / shares $ 250
Warrants Expiration Date Jun. 13, 2017
[1] These warrants have a certain type of cash settlement feature or their exercise prices for which the warrant may be exercised are subject to adjustment for “down-rounds” and the warrants have been accounted for as derivative instruments as described in Note 3, with the exception of 9,704 warrants issued in August 2014.
[2] Due to the issuance of common stock at $1.50 per share as part of the November 2016 Underwritten Offering, the remaining outstanding warrants issued as part of the February 2013 Public Offering were adjusted to reflect the revised exercise price of $1.50 each.
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.7.0.1
STOCKHOLDERS' EQUITY (Details 1) - shares
 3 Months Ended 12 Months Ended
Mar. 31, 2017
Dec. 31, 2016
Number Of Shares Reserved For Future Issuance 9,269,179 12,321,724
Preferred Stock [Member]    
Number Of Shares Reserved For Future Issuance 0 1,133,339
Warrant [Member]    
Number Of Shares Reserved For Future Issuance 8,760,446 10,716,952
Stock options [Member]    
Number Of Shares Reserved For Future Issuance 508,733 471,433
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.7.0.1
STOCKHOLDERS' EQUITY (Details Textual) - USD ($)
 1 Months Ended 3 Months Ended
Mar. 04, 2016
Feb. 08, 2016
Nov. 29, 2016
Nov. 23, 2016
Apr. 20, 2016
Apr. 15, 2016
Mar. 31, 2017
Dec. 31, 2016
Apr. 13, 2016
Class of Warrant or Right [Line Items]                  
Class of Warrant or Right, Number of Securities Called by Warrants or Rights             8,760,446    
Common Stock, Shares Authorized   40,000,000         40,000,000 40,000,000  
Stockholders' Equity, Reverse Stock Split 1-for-10 reverse split At a special meeting held on February 8, 2016, the Companys stockholders approved an amendment to the Companys certificate of incorporation to effect a reverse split of the Companys common stock at a ratio between 1:5 to 1:10 in order to ensure that adequate authorized but unissued shares would be available for anticipated future financings, and to satisfy requirements for the continued listing of the Companys common stock on the NASDAQ Capital Market. In addition, the proposal approved by the stockholders provided that if the reverse split was effected, the number of shares of common stock that the Company is authorized to issue remained unchanged at 40,000,000. The Companys stockholders further authorized the board of directors to determine the ratio at which the reverse split would be effected by filing an appropriate amendment to the Companys certificate of incorporation. The board of directors authorized the ratio of the reverse split on February 24, 2016, and effective at the close of business on March 4, 2016, the Companys certificate of incorporation was amended to effect a 1-for-10 reverse split of the Companys common stock (the 2016 Reverse Split). All share and per share numbers included in these consolidated financial statements give effect to the 2016 Reverse Split.              
Series A Preferred Stock [Member]                  
Class of Warrant or Right [Line Items]                  
Conversion of Stock, Shares Issued             1,133,339    
Preferred Stock Shares Outstanding             0 17  
Series B Pre-Funded Warrant [Member]                  
Class of Warrant or Right [Line Items]                  
Class of Warrant or Right, Exercise Price of Warrants or Rights           $ 0.01      
Warrants Issued To Purchase Common Stock, Shares         1,908,021 1,908,021      
Public Offering Price Per Share Of Shares And Warrants           $ 2.12      
Series A Pre-Funded Warrant [Member]                  
Class of Warrant or Right [Line Items]                  
Class of Warrant or Right, Outstanding           3.04      
Public Offering Price Per Share Of Shares And Warrants           $ 2.13      
Series Z Convertible Preferred Stock [Member]                  
Class of Warrant or Right [Line Items]                  
Warrants Issued To Purchase Common Stock, Shares           492,957      
Series C Pre Funded Warrant [Member]                  
Class of Warrant or Right [Line Items]                  
Net Proceeds From Offering             $ 2,934,759    
Warrants Issued To Purchase Common Stock, Shares             1,956,506    
Underwritten Offering 2016 [Member]                  
Class of Warrant or Right [Line Items]                  
Stock Issued During Period, Shares, New Issues         1,871,321        
Class of Warrant or Right, Exercise Price of Warrants or Rights                 $ 2.13
Stock Issued During Period, Value, New Issues         $ 8,000,000        
Proceeds from Issuance Initial Public Offering         $ 7,200,000        
Ladenburg Thalmann [Member]                  
Class of Warrant or Right [Line Items]                  
Stock Issued During Period, Shares, New Issues           1,378,364      
Class of Warrant or Right, Exercise Price of Warrants or Rights       $ 1.50          
Warrants Issued To Purchase Common Stock, Shares       5,333,356          
Public Offering Price Per Share Of Shares And Warrants       $ 100,000          
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right       66,667          
Ladenburg Thalmann [Member] | Series A Preferred Stock [Member]                  
Class of Warrant or Right [Line Items]                  
Stock Issued During Period, Shares, New Issues       68          
Convertible Preferred Stock, Shares Issued upon Conversion       4,533,356          
Number Of Securities Each Preferred Stock Converted       66,667          
Ladenburg Thalmann [Member] | Underwritten Offering 2016 [Member]                  
Class of Warrant or Right [Line Items]                  
Stock Issued During Period, Value, New Issues     $ 9,200,000            
Proceeds from Issuance Initial Public Offering     $ 8,300,000            
February 2013 Public Offering [Member]                  
Class of Warrant or Right [Line Items]                  
Class of Warrant or Right, Number of Securities Called by Warrants or Rights [1]             38,750    
Class of Warrant or Right, Exercise Price of Warrants or Rights [1],[2]             $ 1.5    
Over-Allotment Option [Member] | Series A Pre-Funded Warrant [Member]                  
Class of Warrant or Right [Line Items]                  
Conversion of Stock, Shares Issued           492,957      
Over-Allotment Option [Member] | Ladenburg Thalmann [Member]                  
Class of Warrant or Right [Line Items]                  
Warrants Issued To Purchase Common Stock, Shares       800,000          
August 2014 Underwritten Offering [Member]                  
Class of Warrant or Right [Line Items]                  
Class of Warrant or Right, Number of Securities Called by Warrants or Rights             9,704    
Common Stock [Member] | Ladenburg Thalmann [Member]                  
Class of Warrant or Right [Line Items]                  
Stock Issued During Period, Shares, New Issues       800,000          
Common Stock [Member] | Over-Allotment Option [Member] | Ladenburg Thalmann [Member]                  
Class of Warrant or Right [Line Items]                  
Stock Issued During Period, Shares, New Issues       800,000          
Series A Warrants [Member]                  
Class of Warrant or Right [Line Items]                  
Warrants Issued To Purchase Common Stock, Shares           3,286,385      
Warrants Issued To Purchase Common Stock, Shares         3,779,342        
Series A Warrants [Member] | Ladenburg Thalmann [Member]                  
Class of Warrant or Right [Line Items]                  
Public Offering Price Per Share Of Shares And Warrants       $ 1.50          
[1] These warrants have a certain type of cash settlement feature or their exercise prices for which the warrant may be exercised are subject to adjustment for “down-rounds” and the warrants have been accounted for as derivative instruments as described in Note 3, with the exception of 9,704 warrants issued in August 2014.
[2] Due to the issuance of common stock at $1.50 per share as part of the November 2016 Underwritten Offering, the remaining outstanding warrants issued as part of the February 2013 Public Offering were adjusted to reflect the revised exercise price of $1.50 each.
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.7.0.1
STOCK-BASED COMPENSATION (Details) - USD ($)
 3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan [Line Items]    
Total stock-based compensation $ 165,674 $ 102,918
Employee and Director Stock Option Grants [Member]    
Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan [Line Items]    
Total stock-based compensation 165,674 103,284
Employee and Director Stock Option Grants [Member] | Research and development [Member]    
Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan [Line Items]    
Total stock-based compensation 16,648 11,035
Employee and Director Stock Option Grants [Member] | General and administrative [Member]    
Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan [Line Items]    
Total stock-based compensation 149,026 92,249
Non Employee Consultant Stock Option Grants [Member]    
Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan [Line Items]    
Total stock-based compensation 0 (366)
Non Employee Consultant Stock Option Grants [Member] | Research and development [Member]    
Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan [Line Items]    
Total stock-based compensation $ 0 $ (366)
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.7.0.1
STOCK-BASED COMPENSATION (Details 1)
 3 Months Ended
Mar. 31, 2017
USD ($)
$ / shares
shares
Share-based Compensation, Stock Options, Activity [Line Items]  
Outstanding - Number of Shares Issuable Upon Exercise of Outstanding Options | shares 471,433
Granted - Number of Shares Issuable Upon Exercise of Outstanding Options | shares 37,300
Expired- Number of Shares Issuable Upon Exercise of Outstanding Options | shares 0
Forfeited - Number of Shares Issuable Upon Exercise of Outstanding Options | shares 0
Outstanding - Number of Shares Issuable Upon Exercise of Outstanding Options | shares 508,733
Vested - Number of Shares Issuable Upon Exercise of Outstanding Options | shares 104,106
Unvested - Number of Shares Issuable Upon Exercise of Outstanding Options | shares 404,627
Exercisable - Number of Shares Issuable Upon Exercise of Outstanding Options | shares 104,106
Outstanding - Weighted Average Exercise Price (in dollars per share) | $ / shares $ 7.59
Granted - Weighted Average Exercise Price (in dollars per share) | $ / shares 2.18
Expired- Weighted Average Exercise Price (in dollars per share) | $ / shares 0
Forfeited - Weighted Average Exercise Price (in dollars per share) | $ / shares 0
Outstanding - Weighted Average Exercise Price (in dollars per share) | $ / shares 7.19
Vested - Weighted Average Exercise Price (in dollars per share) | $ / shares 19.84
Unvested - Weighted Average Exercise Price (in dollars per share) | $ / shares 3.94
Exercisable - Weighted Average Exercise Price (in dollars per share) | $ / shares $ 19.84
Vested - Weighted Average Remaining Contracted Term in Years 8 years 8 months 12 days
Unvested - Weighted Average Remaining Contracted Term in Years 9 years 2 months 1 day
Exercisable - Weighted Average Remaining Contracted Term in Years 8 years 8 months 12 days
Vested - Aggregate Intrinsic Value (in dollars) | $ $ 54,579
Unvested - Aggregate Intrinsic Value (in dollars) | $ 167,134
Exercisable - Aggregate Intrinsic Value (in dollars) | $ $ 54,579
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.7.0.1
STOCK-BASED COMPENSATION (Details Textual) - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2017
Dec. 31, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Employee Service Share Based Compensation Nonvested Total Compensation In Current Year $ 372,648  
Employee Service Share Based Compensation Nonvested Total Compensation In Year Two 391,798  
Employee Service Share Based Compensation Nonvested Total Compensation In Year Three $ 186,079  
Share Based Compensation Arrangement By Share Based Payment Award Options Unvested and Expected To Vest Outstanding Number (in shares) 3.20  
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized $ 950,882  
Employee Service Share Based Compensation Nonvested Total Compensation In Year Four $ 357  
Share Based Compensation Arrangement By Share Based Payment Award, Options, Vested and Expected To Vest, Outstanding, Number 104,106  
Employee [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Annual Forfeiture Rate Percentage 2.00% 2.00%
Director [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Annual Forfeiture Rate Percentage 2.00% 2.00%
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.7.0.1
NET INCOME (LOSS) PER SHARE (Details) - Convertible Debt [Member] - shares
 3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Warrants [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 8,760,446 782,782
Stock options [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 508,733 68,582
EXCEL 42 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 44 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 46 FilingSummary.xml IDEA: XBRL DOCUMENT 3.7.0.1 html 116 150 1 true 43 0 false 4 false false R1.htm 101 - Document - Document And Entity Information Sheet http://www.novelos.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 102 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://www.novelos.com/role/CondensedConsolidatedBalanceSheets CONDENSED CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 103 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS [Parenthetical] Sheet http://www.novelos.com/role/CondensedConsolidatedBalanceSheetsParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS [Parenthetical] Statements 3 false false R4.htm 104 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.novelos.com/role/CondensedConsolidatedStatementsOfOperations CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 105 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.novelos.com/role/CondensedConsolidatedStatementsOfCashFlows CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 5 false false R6.htm 106 - Disclosure - NATURE OF BUSINESS, ORGANIZATION AND GOING CONCERN Sheet http://www.novelos.com/role/NatureOfBusinessOrganizationAndGoingConcern NATURE OF BUSINESS, ORGANIZATION AND GOING CONCERN Notes 6 false false R7.htm 107 - Disclosure - FAIR VALUE Sheet http://www.novelos.com/role/FairValue FAIR VALUE Notes 7 false false R8.htm 108 - Disclosure - STOCKHOLDERS' EQUITY Sheet http://www.novelos.com/role/StockholdersEquity STOCKHOLDERS' EQUITY Notes 8 false false R9.htm 109 - Disclosure - NOTES PAYABLE Notes http://www.novelos.com/role/NotesPayable NOTES PAYABLE Notes 9 false false R10.htm 110 - Disclosure - STOCK-BASED COMPENSATION Sheet http://www.novelos.com/role/StockbasedCompensation STOCK-BASED COMPENSATION Notes 10 false false R11.htm 111 - Disclosure - INCOME TAXES Sheet http://www.novelos.com/role/IncomeTaxes INCOME TAXES Notes 11 false false R12.htm 112 - Disclosure - NET INCOME (LOSS) PER SHARE Sheet http://www.novelos.com/role/NetIncomeLossPerShare NET INCOME (LOSS) PER SHARE Notes 12 false false R13.htm 113 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://www.novelos.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 13 false false R14.htm 114 - Disclosure - NATURE OF BUSINESS, ORGANIZATION AND GOING CONCERN (Policies) Sheet http://www.novelos.com/role/NatureOfBusinessOrganizationAndGoingConcernPolicies NATURE OF BUSINESS, ORGANIZATION AND GOING CONCERN (Policies) Policies 14 false false R15.htm 115 - Disclosure - FAIR VALUE (Tables) Sheet http://www.novelos.com/role/FairValueTables FAIR VALUE (Tables) Tables http://www.novelos.com/role/FairValue 15 false false R16.htm 116 - Disclosure - STOCKHOLDERS' EQUITY (Tables) Sheet http://www.novelos.com/role/StockholdersEquityTables STOCKHOLDERS' EQUITY (Tables) Tables http://www.novelos.com/role/StockholdersEquity 16 false false R17.htm 117 - Disclosure - STOCK-BASED COMPENSATION (Tables) Sheet http://www.novelos.com/role/StockbasedCompensationTables STOCK-BASED COMPENSATION (Tables) Tables http://www.novelos.com/role/StockbasedCompensation 17 false false R18.htm 118 - Disclosure - NET INCOME (LOSS) PER SHARE (Tables) Sheet http://www.novelos.com/role/NetIncomeLossPerShareTables NET INCOME (LOSS) PER SHARE (Tables) Tables http://www.novelos.com/role/NetIncomeLossPerShare 18 false false R19.htm 119 - Disclosure - NATURE OF BUSINESS, ORGANIZATION AND GOING CONCERN (Details Textual) Sheet http://www.novelos.com/role/NatureOfBusinessOrganizationAndGoingConcernDetailsTextual NATURE OF BUSINESS, ORGANIZATION AND GOING CONCERN (Details Textual) Details http://www.novelos.com/role/NatureOfBusinessOrganizationAndGoingConcernPolicies 19 false false R20.htm 120 - Disclosure - FAIR VALUE (Details) Sheet http://www.novelos.com/role/FairValueDetails FAIR VALUE (Details) Details http://www.novelos.com/role/FairValueTables 20 false false R21.htm 121 - Disclosure - FAIR VALUE (Details 1) Sheet http://www.novelos.com/role/FairValueDetails1 FAIR VALUE (Details 1) Details http://www.novelos.com/role/FairValueTables 21 false false R22.htm 122 - Disclosure - FAIR VALUE (Details 2) Sheet http://www.novelos.com/role/FairValueDetails2 FAIR VALUE (Details 2) Details http://www.novelos.com/role/FairValueTables 22 false false R23.htm 123 - Disclosure - FAIR VALUE (Details 3) Sheet http://www.novelos.com/role/FairValueDetails3 FAIR VALUE (Details 3) Details http://www.novelos.com/role/FairValueTables 23 false false R24.htm 124 - Disclosure - FAIR VALUE (Details Textual) Sheet http://www.novelos.com/role/FairValueDetailsTextual FAIR VALUE (Details Textual) Details http://www.novelos.com/role/FairValueTables 24 false false R25.htm 125 - Disclosure - STOCKHOLDERS' EQUITY (Details) Sheet http://www.novelos.com/role/StockholdersEquityDetails STOCKHOLDERS' EQUITY (Details) Details http://www.novelos.com/role/StockholdersEquityTables 25 false false R26.htm 126 - Disclosure - STOCKHOLDERS' EQUITY (Details 1) Sheet http://www.novelos.com/role/StockholdersEquityDetails1 STOCKHOLDERS' EQUITY (Details 1) Details http://www.novelos.com/role/StockholdersEquityTables 26 false false R27.htm 127 - Disclosure - STOCKHOLDERS' EQUITY (Details Textual) Sheet http://www.novelos.com/role/StockholdersEquityDetailsTextual STOCKHOLDERS' EQUITY (Details Textual) Details http://www.novelos.com/role/StockholdersEquityTables 27 false false R28.htm 128 - Disclosure - STOCK-BASED COMPENSATION (Details) Sheet http://www.novelos.com/role/StockbasedCompensationDetails STOCK-BASED COMPENSATION (Details) Details http://www.novelos.com/role/StockbasedCompensationTables 28 false false R29.htm 129 - Disclosure - STOCK-BASED COMPENSATION (Details 1) Sheet http://www.novelos.com/role/StockbasedCompensationDetails1 STOCK-BASED COMPENSATION (Details 1) Details http://www.novelos.com/role/StockbasedCompensationTables 29 false false R30.htm 130 - Disclosure - STOCK-BASED COMPENSATION (Details Textual) Sheet http://www.novelos.com/role/StockbasedCompensationDetailsTextual STOCK-BASED COMPENSATION (Details Textual) Details http://www.novelos.com/role/StockbasedCompensationTables 30 false false R31.htm 131 - Disclosure - NET INCOME (LOSS) PER SHARE (Details) Sheet http://www.novelos.com/role/NetIncomeLossPerShareDetails NET INCOME (LOSS) PER SHARE (Details) Details http://www.novelos.com/role/NetIncomeLossPerShareTables 31 false false All Reports Book All Reports clrb-20170331.xml clrb-20170331.xsd clrb-20170331_cal.xml clrb-20170331_def.xml clrb-20170331_lab.xml clrb-20170331_pre.xml true true ZIP 48 0001144204-17-026247-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001144204-17-026247-xbrl.zip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�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